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A bstract
A bstract
1. The effects of adenosine agonists and antagonists were examined on 
population excitatory postsynaptic potential (population EPSP) slopes, 
population spike (PS) amplitudes and the relationship between the two 
i.e. EPSP-spike (E-S) coupling. Activation or blockade of adenosine À2a 
receptors responses, evoked by stimulation in the stratum radiatum, had 
no effect on these parameters. However, activation of the adenosine A| 
receptor using N^-cyclopentyladenosine (CPA) resulted in a significant 
decrease in both population EPSP and population spike.
2. When adenosine Ai receptors were activated using CPA (50 nM) the 
decrease in population spike amplitude was greater than could be 
accounted for by the decrease in population EPSP, resulting in a 
dissociation in the EPSP-spike relationship as measured by a right-shift in 
the E-S curve or a decrease in the ratio PS/EPSP.
A3. When adenosine Ai and A%A receptors were activated at the same time t
using CPA and 2-[p-(carboxyethyl)-phenylethylamino]-5’-N- 
ethylcarboxamidoadenosine (CGS 21680) respectively, the depression of '
the E-S relationship was significantly attenuated. This was due to a 
mainly postsynaptic effect whereby activation of AiA receptors 
signiEcantly attenuated the postsyiiaptic elevation of action potential 
threshold by adenosine Ai receptor activation.
A bs trac t
4. The use of a variety of signal transduction modulators suggested that 
adenylate cyclase, protein kinases or nitric oxide were not involved in the 
interaction between A% and Ai receptors.
5. Blocking potassium channels with barium or glibenclamide reduced the 
inhibitory effects of CPA on population spike amplitude but not 
population EPSP slope and attenuated the inhibitory effects of adenosine 
Ai receptor activation on E-S coupling in a similar mamier to adenosine 
AiA receptor activation. The increases in the ratio PS/EPSP seen when 
Aza receptors were activated with CGS 21680 or when potassium 
channels were blocked with barium were not significantly different, 
suggesting that a change in postsynaptic potassium conductance may 
underlie the antagonistic effect of adenosine Aza receptor activation on 
A 1-mediated responses.
6. Application of ATP 10 pM to hippocampal slices initially decreased 
population spike amplitude and then produced long-term potentiation 
(LTP). 2.5 pM ATP also resulted in LTP of responses although did not 
inhibit the potentials during perfusion.
7. The stable analogue of ATP, ap-methyleneATP had no long-term effects 
on potentials. Blocking P2 receptors (with suramin) or N-methyl-D- 
aspartate (NMDA) receptors prevented the induction of LTP. When 
adenosine Ai receptors were blocked or the slices superfused with 
adenosine deaminase no inhibition of responses was seen during
A bs trac t
perfusion with ATP, nor was LTP induced. Adenosine itself did not 
induce LTP. These results suggest that induction of LTP following ATP 
perfusion requires the activation of both P2 and Ai receptors.
8. During superfusion with ZM 241385, ATP 10 pM still induced LTP but 
no longer caused the inliibition of responses during perfusion.
9. Following electrically induced LTP (100 Hz for 1 second), perfusion of 
ATP caused no further potentiation of responses, suggesting that 
electrically and ATP induced LTP share common mechanisms.
10. Perfusion of a preparation of 5’adenylic acid deaminase (AMPase) from 
Aspergillus species for 10 min resulted in an initial increase in population 
spike amplitude which gave way to a decrease in potential size and EPSP 
slope that remained depressed for at least 30 min following washout of 
the enzyme, resulting in long-term depression (LTD). A decrease in 
EPSP-spike coupling was observed 30 min following washout of enzyme. 
Superfusion of AMPase on slices in which transmission had been 
potentiated using high frequency stimulation resulted in depotentiation of 
responses.
11. The LTD caused by AMPase could not be inhibited by the allosteric 
inhibitor of the enzyme 2,3-diphosphoglyceric acid. Further investigation 
also ruled out the involvement of nitric oxide, protein kinase, and
IV
A bstrac t
cyclooxygenase in the activity of the AMPase. The use of AMPase 
extracted from rabbit muscle resulted in no LTD of responses.
12. Analysis of the crude enzyme extract from Aspergillus revealed that the 
preparation was not pure. Separation of the various components in the 
crude preparation led to the discovery that the AMPase was not the active 
factor causing depression of evoked responses.
13. Further purification of the active protein and subsequent sequencing 
showed that the protein was similar to a (3-glucosidase. However, 
perfusion of (3-glucosidase extracted from almonds did not result in LTD 
of responses.
14. Overall, this thesis extends loiowledge of how synaptic transmission can 
be modulated by purines, and raises the possibility that a new family of 
proteins, related structurally to glucosidases, may also affect synaptic 
plasticity.
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Digging
hy Seamus Heaney
Between my finger and my thumb 
The squat pen rests: snug as a gun.
Under my window, a clean rasping sound 
When the spade sinks into gravelly ground;
My father, digging. I  look down
Till his straining rump among the flowerbeds 
Bends low, comes up tM>enty years away 
Stooping in rhythm through potato drills 
Where he was digging.
The coarse boot nestled on the lug, the shaft 
Against the inside knee was levered firmly.
He rooted out tall tops, buried the bright edge deep 
To scatter new potatoes that we picked 
Loving their cool hardness in our hands.
By God, the old man could handle a spade.
Just like his old man.
My grandfather cut more turf in a day 
Than any other man on Toner's bog.
Once 1 carried him milk in a bottle
Corked sloppily with paper. He straightened up
To drink it then fell to right away
Nicking and slicing neatly, heaving sods 
Over his shoulder, going down and down 
For the good turf. Digging.
The cold smell o f potato mould, the squelch and slap 
O f soggy peat, the curt cuts o f an edge 
Through living roots awaken in my head.
But I've no spade to follow men like them.
Between my finger and my thumb 
The scjuat pen rests.
I'll dig with it.
X X lll
in troduction
L The Hippocampus.
investigations that follow.
hippocampus encompasses the hippocampus proper and fascia denta or dentate
%
»
CHAPTER 1.
INTRODUCTION.
'= 'r
This thesis is concerned with the plasticity of area CAl in the rat hippocampus, 
including the induction of long-term potentiation and long-term depression of 
evoked field potentials recorded extracellularly in the stratum pyramidale.
iChanges in synaptic efficiency utilising simultaneous recordings of population 
excitatory postsynaptic potentials (EPSP) and population spikes from the stratum 
radiatum and stratum pyramidale respectively will also be described in terms of
V
changes in the EPSP-spike relationship.
All the experiments undertaken in this study have been carried out in the rat 
hippocampal slice preparation. The following section will give an account of the 
properties of this preparation and provide the rationale for its choice in the
Hippocampal anatomy.
In the brains of mammals the hippocampus is a bilateral curved structure found 
within the forebrain located beneath the posterior and temporal neocortex 
(O’Keefe & Nadel, 1978). In most species, including the human, the 
hippocampus appears as a ridge extending nearly the entire length of each lateral 
ventricle. The white outer coating (the alveus) is composed of myelinated fibres, 
most of which leave the region via a large efferent pathway, the fornix. The term
in trodu ction
gyrus. The hippocampal formation includes both these and also the surrounding 
cortical areas. Differences in cell morphology and fibre projections led to the 
division of the hippocampus proper into the regio superior and regio inferior 
(Cajal, 1911; Blackstad, 1956). The anatomist Lorente de No (1934) divided the 
hippocampus proper into four subfields using the Golgi method of staining. 
These subfields, termed cornu ammonis (CA) 1-4. Area CAl corresponds to the 
regio superior while CA2 and CA3 correspond to the regio inferior. The CA4 
region represents cells at the transition of the hippocampus and dentate gyrus.
There has been some question as to whether a CA2 region should be considered 
distinct from the adjacent CAl and CA3 areas (e.g. Blackstad, 1956). However, 
ontogenetically the CA2 region develops two to three days earlier than CAl and 
CA3 in the rat. It also shows a higher resistance to destruction by kainate 
administration than the adjacent CA areas implying that it has distinct properties 
relative to its neighbours. Ishizuka et al. (1990) using horseradish peroxidase 
and computer aided digitising support the existence of an anatomically distinct 
CA2 region in the rat.
Cajal (1968) divided the hippocampus proper into several layers. From the outer 
layer to the more medial these include the alveus, the stratum oriens which 
contains the basal dendrites of the pyramidal cells, the stratum pyramidale 
containing the pyramidal cell bodies, the stratum radiatum consisting mainly of 
proximal dendrites and their arborizations from the pyramidal cells, the stratum 
lacunosum, in which bundles of fibres aie found of which some are from the 
CA3 region and also a number of cells of random organisation, and finally the
in troduction
Stratum, moleculare. The dentate gyms consists of closely packed cells (granule 
cells) which have dendritic brushes that extend to the outer molecular layer of the 
gyrus (Isaccson, 1987).
Neuronai circuitry in the CAl area.
The main excitatory input to the CAl area of the hippocampus is from axon 
collaterals of the CA3 pyramidal cells i.e. Schaffer collaterals. This is the last 
stage in the tri-synaptic pathway from the entorhinal cortex which synapses with 
the pyramidal cell apical dendrites in the stratum radiatum (Andersen et a l,
-1966, 1971b). Neuronal outputs from the CAl cells exit into the alveus and 
fornix to the lower brain areas and also project to the subicular region (Isaccson,
1987).
■I
I
Inhibitory pathways also exist in the CAl area. Both feedforward (occurring 
before activation of the pyramidal cells) and feedback (initiated by axon 
collaterals of the pyramidal cells that reach the interneurones) inhibitory 
pathways have been described. A type of hippocampal interneurone, the basket 
cell, found in the pyramidal layer and stratum oriens makes contact with 
numerous pyramidal cells to exert inhibitory influences. The basket cells mainly 
use the inhibitory transmitter y-aminobutyric acid (GABA). Hippocampal
interneurones are extremely sensitive to afferent stimulation and can be activated 
at lower intensities than those required to produce similar effects in pyramidal 
cells; it is on this basis that interneurones are thought to provide both 
feedforward and feedback inlribition.
in troduction
Hippocampal slices.
Slices of mammalian CNS tissue were shown to be physiologically viable in
vitro by Yamamoto & Mcllwain (1966) using neocortical tissue. Since then, the
.slice preparation has been extensively employed in neurochemical and
electrophysiological experiments and has virtually replaced the intact animal 
.preparation for researchers interested in intracellular and membrane phenomena 
in the mammalian central nervous system. In vitro/in vivo studies by Sla*ede &
Westguard (1971) comparing the effects of electrical stimulation revealed that 
the fundamental properties of the hippocampus such as inlribitory mechanisms, 
postactivation facilitation, frequency potentiation and post-tetanic potentiation 
are preserved in vitro. The lamellar structure of the hippocampus (Andersen et 
al,  1971b), with its rather simple three-layered cortex, well defined input and 
output pathways make it an excellent candidate for a slice preparation 
(Schwartzkroin, 1987). I
Advantages of the slice preparation include:
a. Technical simplicity compared with in vivo experiments.
b. Good control over the condition of the preparation. For example the ionic 
environment, pO] and temperature can be tightly controlled and 
manipulated. Also the variable effects of anaesthesia on the intact animal 
are not a problem in the slice preparation.
c. No pulsation. The slice tissue is stabilised in the recording chamber and 
is not subjected to movements caused by heart beat and respiration.
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d. Improved visualisation of tissue. It is easy to visually guide recording and 
stimulating electrodes to their desired sites under low magnification
e. Direct access to the extracellular space. This means that drugs or putative 
transmitter substances can be easily tested by addition to the bathing 
medium.
f. Simplified preparation. Removing the tissue from the rest of the brain 
means it is no longer subject to neurohumoral effects or to inputs from 
distant brain regions.
The advantages of the slice preparation led increasing numbers to adopt this 
technique. However, as with most preparations the slice has drawbacks. In 
general, the limitations of the slice preparation stem from that fact that the tissue 
is not in a normal state. These limitations include;
a. Separation form normal inputs. Tonic excitatory and/or inhibitory 
influences, and long feedback loops are lost. Also local circuits 
orientated out of the plane of the slice may be interrupted.
b. The ionic environment does not mimic exactly the normal extracellular 
conditions in vivo.
c. The slicing process will damage some tissue. In general the slice 
preparation contains a region of intact tissue surrounded by two layers of 
damaged tissue (Bak et al ,  1980).
d. The tissue is subject to an anoxic period during preparation (Tipton and 
Whittingham, 1979).
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IL Synaptic plasticity in the hippocampus.
Compelling evidence from lesion studies in higher primates, including humans, 
shows that the hippocampus is a critical component of a neural system that is 
required for the initial storage of long-term memory (Squire & Zola-Morgan, 
1991). It has been postulated that long-lasting modifications in synaptic strength 
are required to accomplish this feat. Such modifications of synaptic strength 
include long-term potentiation (LTP) and long-term depression (LTD).
Long-term potentiation
Bliss & Lomo (1972, 1973) showed that brief high frequency stimulation of 
hippocampal pathways could evoke an increase in synaptic efficiency in the 
anaesthetised rabbit. This phenomenon was later described in the hippocampal T
slice preparation (Schwartzkroin & Webster, 1975; Alger & Tyler, 1976;
i!
Andersen et al ,  1977; Lynch et al ,  1977; Yamamoto & Chujo, 1978). Several 
properties of LTP make it an attractive cellular mechanism for memory 
formation (Bliss & Collingridge, 1993);
Like memories, LTP can be formed rapidly and is strengthened by 
repetition.
It exhibits input specificity i.e. it occurs at synapses stimulated by 
afferent activity but not at adjacent synapses on the same postsynaptic 
cell. y
LTP is associative i.e. temporally pairing activity in a weak input with y
activation of a strong input will result in LTP of the weak input.
y■fil
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It is well established that induction of LTP requires activation of postsynaptic N- 
methyl-D-aspartate (NMDA) receptors resulting in an increase in the 
intracellular calcium concentration, [Ca^’*'], (Collingridge & Lester, 1989). It has 
been suggested that during normal synaptic transmission, glutamate acts on both 
NMDA and AMP A receptors. Na'  ^ flows tlii'ough a- amino - 3 -hydroxy- 5 -methy 1 - 
4-isoazolepropionate (AMPA) receptor channels but not NMDA receptor 
channels due to blockade by Mg^ "*". Depolarisation of the postsynaptic cell 
during high frequency stimulation releases the Mg^^ blockade allowing Na^ and 
Ca^^ to flow through the NMDA receptor channel. This increase in [Ca^’fi is a 
necessary trigger for the events leading to LTP (Bliss & Collingridge, 1993).
However, a threshold increase in [Ca^^ji may not be the sole trigger for LTP.
The degree of activation of NMDA receptors and the magnitude of increase in 
[Ca^^ji within the spine may affect the stability and duration of LTP (Malenlca &
Nicholl, 1993). Afferent activity may also be essential (Kullman et al ,  1993).
Also metabotropic glutamate receptors, which typically couple to 
phospoinositide turnover may need to be activated for LTP to occur (Bashir et 
oA,1993y
Protein Kinases and signal transduction mechanisms in LTP.
The majority of work on the signal transduction processes for the conversion of 
the initial trigger signal for LTP into long-lasting modifications of protein has 
focused on the role of protein kinases, in particular Ca^^/calmodulin-dependent 
protein kinase II (CaMKII), protein kinase C (PICC) and the tyrosine kinase, Fyn.
Inhibitors of these enzymes have been shown to block LTP (Bliss &
.V,:I
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Collingridge, 1993). However, gene-targeting approaches to produce 
“knockouts” of CaMKII, PKC or Fyn showed that induction of LTP was more 
difficult to elicit in these animals, but was not absent (Grant & Silva, 1994; 
Abeliovich et al ,  1993), suggesting the presence of compensatory redundant 
mechanisms in the LTP signalling cascade.
The role of purines in the expression of LTP.
j
Although the activation of NMDA receptors is an event considered important for 
the induction of LTP in the hippocampus, many other factors are thought to be
involved in synaptic plasticity. For example, arachidonic acid caused a synaptic 
enhancement when accompanied by presynaptic activity (Williams et al,  1989). 
Collins et al  (1995) also demonstrated an interaction between arachidonic acid 
and metabotropic glutamate receptors to produce an NMDA-indpendent LTP. 
Nitric oxide and carbon monoxide may also be involved in NMDA receptor- 
independent synaptic plasticity (Zhuo et al ,  1993) as well as platelet activating 
factor (Kato et al ,  1994) and interluekin-Ip (Coogan & O’Connor, 1999). In 
addition, purinergic compounds have been shown to play an important role in 
long-term plasticity in the hippocampus. Activation of adenosine Ai receptors 
has been shown to inhibit the induction of LTP (Arai et al ,  1990; de Mendonca 
& Ribeiro, 1990) perhaps due to its inhibitory effects on transmitter release, 
whereas adenosine A% receptors have been implicated in the induction (Kessey & 
Mogul, 1997; Kessey et al ,  1997) and facilitation of LTP (Sekino et al ,  1991; 
Forghani & Kimjevic, 1995). These receptors have been shown to signal via 
phospholipase C and therefore can increase the intracellular calcium 
concentration in the cell. Adenosine Ai receptors can induce an NMDA receptor-
..: j '
in troduction
independent LTP by potentiating postsynaptic AMPA receptors in the CAl area 
of rat hippocampus (Kessey & Mogul, 1997).
Exogenously applied adenosine 5 Triphosphate (ATP) is able to induce long- 
lasting enhancement of the population spikes recorded from mouse (Wieraszko 
& Seyfried, 1989) and guinea-pig (Fujii et ai ,  1995) hippocampal slices. The 
mechanism(s) by which ATP induces LTP in the hippocampus may involve 
activation of a subclass of ATP (P2) receptor, or hydrolysis by ecto-nucleotidase 
to adenosine. Alternatively, it may be possible that ecto-protein kinase, using 
extracellular ATP as a co-substrate, is involved in the underlying synaptic 
plasticity (Wieraszko & Ehrlich, 1994).
EPSP-spike Relationship.
In the first report of LTP in the hippocampus Bliss & Lomo (1973) showed a 
change in the population spike (PS) that could not be accounted for by the 
change in population excitatory postsynaptic potential (EPSP). By plotting PS 
latency (which varies inversely with PS amplitude), against EPSP amplitude, 
they found a downward shift following LTP induction. Andersen et al. (1980) 
plotted PS amplitude against EPSP slope and used the term EPSP-to-spike (E-S) 
potentiation to describe the upward shift following LTP.
The relationship between the slope of the population excitatory postsynaptic 
potential (EPSP) and the corresponding population spike (PS) amplitude at a 
given stimulus intensity gives an indication of the ability of the excitatory 
synaptic drive to induce an action potential in the postsynaptic cell. In other
in troduction
words, the E-S relationship inclusively describes the input-output relationship for 
a population of neurones, including pre- and postsynaptic effects on the 
postsynaptic potential, network effects and action potential generation.
By varying stimulation intensity, it is possible to construct input-output graphs 
for PS amplitude or EPSP slope against intensity. From these curves it is then 
possible to plot an E-S curve by plotting the PS amplitude as a function of EPSP 
slope for the various stimulation intensities. A change in the E-S relationship 
indicates the probability of discharge of the postsynaptic cell is modified in 
response to an identical synaptic event. E-S potentiation occurs when neuronal 
populations produce more action potentials for a given amount of synaptic input. 
Conversely, E-S depression is observed when fewer action potentials are seen 
following a given synaptic input.
It has been suggested that changes in the E-S relationship are as important as 
LTP and LTD, in terms of information processing, as it provides the neuronal 
network with another variable, increasing the capacity for memory storage 
(Bernard & Wheal, 1995). The mechanisms of E-S modification are thought to 
be at least partly independent from those involved in LTP and LTD due to the 
fact that E-S potentiation can occur even when NMDA receptors (which, as 
already mentioned, are thought to be essential in both LTP and LTD) are blocked 
(Bernard & Wheal, 1995).
Long-term depression.
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Homo synaptic LTD in the CAl area of the hippocampus is usually induced by 
prolonged low-frequency stimulation (LFS), the most common protocol used 
being 900 pulses at IHz. Unlike LTP, which can be induced robustly, and 
consistently using high-frequency stimulation, a reliable method for induction of 
LTD has proved more elusive. LTD can be elicited reliably only in slices from 
young rats up to six weeks-of-age (Dudek & Bear, 1992; Staubli & Ji, 1996). In 
fact, LTD expression in rats older than eight to ten weeks has very seldom been 
reported (Barnes, 1979; Heynen ei ai ,  1996). In contrast, LTP of a specific set 
of synapses can readily be reversed using the same stimulation paradigms as 
those used to induce LTD in naive (unpotentiated) slices (Baskys & Malenka,
11
Î
Long-term depression (LTD) was originally reported in the CAl area of the 
hippocampus as a heterosynaptic correlate of homosynaptic LTP in this area 
(Lynch et al ,  1977). Later, heterosynaptic LTD was also seen in the dentate 
gyrus (Levy & Stewart, 1979; Abraham & Goddard, 1983; Levy & Stewart,
!
1983) and a homosynaptic form of LTD was found in the CAl area of the
;hippocampus (Dudek & Bear, 1992; Mulkey & Malenka, 1992) and also in other 
brain regions (Linden, 1994). Surprisingly, LTD in the CAl area of the 
hippocampus shares several features with LTP in that it is input specific, requires 
activation of NMDA type glutamate receptors and influx of Ca^  ^ through 
channels coupled to these receptors (Dudek & Bear, 1992; Mulkey & Malenka,
1992; Neveu & Zuker, 1996). This suggests that the same receptors but different 
efffectors are involved in these two types of plasticity. However, as with LTP 
forms of NMDA receptor-independent LTD have been described (Berretta &
Cherubini, 1998; Tzounopoulos el al ,  1998).
1
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1991). This reversal of LTP was first reported by Barrionuevo et al  (1980) and 
has been termed depotentiation (Fujii et al ,  1991). It is unclear whether LTD 
and depotentiation are the same process mediated by the same effector system 
(see e.g. Wagner & Alger, 1996).
The long-term plastic changes in synaptic function described above provide the 
best available model for the mechanism by which the brain stores information. 
The mechanisms underlying LTP and LTD provide the strongest clues for the 
experimental analysis of the physical substrate of memory. It is likely that these 
mechanisms are multifactorial, controlled by a network of interacting signalling 
cascades regulated at multiple levels.
HI. Adenosine 5’triphosphate.
Adenosine triphosphate (ATP) is an ubiquitous intracellular energy source 
fundamentally involved in various metabolic cycles including energy metabolism 
and nucleic acid synthesis. The first investigators to recognise the potent 
extracellular effects of purine nucleotides were Drury & Szent-Gyorgyi (1929), 
with special reference to their actions in the mammalian heart. Following this 
report, further work with regard to the actions of ATP and its metabolite, 
adenosine, on the cardiovascular system was carried out as reviewed by Green & 
Stoner (1950).
12
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An important advance was made by Holton (1959), who showed that antidromic
■y
S t im u la t io n  of t h e  g r e a t  a u r ic u la r  n e r v e  - which r e s u l t s  in  v a s o d i l a t i o n  of th e Irabbit ear vessels - was accompanied by ATP release. In the early sixties non-
adrenergic, non-cholinergic (NANC) nerves were described in the h
gastrointestinal tract (Burnstock et al ,  1964). Burnstock (1972), using the icriteria summarised by Eccles (1964) for the acceptance of putative 
neurotransmitters, proposed that the substance released in response to autonomic 
nerve stimulation was ATP and termed the nerves involved “purinergic”.
Supporting the idea that ATP was a neurotransmitter were the observations that TIATP was synthesised, stored and released from non-adrenergic, non-cholinergic |Inerves supplying the intestine and that it mimicked the effects of nerve 
stimulation on these muscles (Burnstock et al ,  1970).
Evidence for pre-junctional purinergic receptors was obtained from experiments 
in the skeletal neuromuscular junction. In the isolated rat phrenic nerve - 
diaphragm preparation, adenosine and the adenine nucleotides decreased both the 
spontaneous and evoked release of acetylcholine from motor nerve terminals 
(Ginsborg & Hirst, 1972; Ginsborg et al ,  1973; Ribeiro & Walker, 1973).
Noradrenaline release from sympathetic nerves was also shown to be inhibited . ;
by purine compounds in a wide variety of tissues (Hedqvist & Fredholm, 1976; T
JSu, 1978). In 1979 it was shown that these prejunctional neuromodulatory effects 
of adenine nucleotides were mediated by receptors for adenosine, but not for 
A TP(D eM eye/fl/., 1979).
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The demonstration that release of both [^H]ATP and noradrenaline was blocked 
by giianethidine during stimulation of sympathetic nerves supplying guinea pig 
taenia coli gave the first indication that ATP may be released as a co-transmitter 
with noradrenaline (Sit et al ,  1971). This coticept was later extended to other 
tissues (Langer & Pinto, 1976; Burnstock, 1976, Burnstock, 1990).
ATP receptors.
In 1978 Burnstock proposed a basis for distinguishing two types of purinergic 
receptor namely the Pi and P2 purinoceptors.
This classification was based on four criteria:
1. The relative potencies of ATP, ADP, AMP and adenosine.
2. The selective actions of antagonists especially the methyIxanthines.
3. The activation of adenylate cyclase by adenosine but not ATP.
4. The induction of prostaglandin synthesis by ATP but not by adenosine.
Thus, Pi receptors are more selective for adenosine, act through adenylate 
cyclase and are antagonised by lower concentrations of methylxanthines than 
produce phosphodiesterase inhibition. P2 receptors are more responsive to ATP 
and ADP than AMP and adenosine, are not antagonised by methylxanthines, do 
not act via adenylate cyclase and their occupation may lead to prostaglandin 
synthesis.
14
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P2 receptors were further subdivided into P2X and P2Y receptor subtypes on the 
basis of pharmacological studies using isolated preparations from a number of 
species (Burnstock & Kennedy, 1985). In addition to this pharmacological 
distinction, it became clear that the subtypes also differed in their transduction 
mechanisms. P2X receptors are transmitter-gated ion channels whereas P2Y 
receptors are members of the G-protein coupled superfamily (Keimedy, 1990; 
Dubyak, 1991; Abbracchio & Burnstock, 1994, Fredholm et al ,  1994). During 
this time a number of other subtypes of P2 receptor were claimed, including an 
ADP selective P2T receptor responsible for platelet aggregation (Gordon, 1986), 
a P2Z receptor on mast cells (Gordon, 1986), a P2U receptor showing 
equipotency to ATP and UTP (O’Connor et al ,  1991), and a specific receptor for 
diadenosine polyphosphates, termed a P2D receptor (Pintor & Miras-Portugal,
1993). This method of nomenclature, described as a “random walk through the 
alphabet” was deemed unsatisfactory and a new method proposed by Abbracchio 
& Burnstock (1994).
P2X receptors.
The first P2X receptors were cloned in 1994 - P2Xi from the rat vas deferens 
(Valera et al ,  1994) and P2X] from rat PC12 cells (Brake et al ,  1994). Since 
then the many genes that encode P2X subunits have been cloned from a variety 
of sources. Currently, seven distinct subunits are known to exist, and all can 
apparently form homomeric channels. However it is likely that in nature they 
exist as heteromeric assemblies.
15
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P2X receptors have two hydrophobic transmenibrane domains per subunit, 
intracellular N- and C- domains and a large extracellular loop which always 
contains 10 cystines (Brake et al ,  1994; North, 1996). The channel pore has 
been shown to be lined by residues from the second transmembrane domain 
(Rassendren o/,, 1997).
All P2X subunits form functional channels when expressed in expression 
systems such as the Xenopus oocyte or CPIO cells. These presumably 
homomeric receptors show properties similar to P2X receptors identified in 
native cell types, suggesting that the native cell types may express homomeric 
P2X receptors as well, with subtypes P2Xi, P2 X2 and P2X] most likely to form 
homo mers (Rae et al ,  1988). However, many native cell types express multiple 
P2X subunit niRNA transcripts, which is reflected at the protein level using 
detection by immunocytochemistry (Kidd ei al ,  1995; Collo et al,  1996; 
Vulchanova et al ,  1996). The possibility of heteropolymerisation between 
different P2X subunits therefore clearly exists. It has been shown that P2 X2 and 
P2 X3 subunits can form heteromeric channels (Lewis et al ,  1995; Radford et al,  
1997), as can P2 X4 and P2Xg subunits (Le at al., 1998). The overlapping of P2X 
subunits in CNS neurones is suggestive of heteropolymerisation (Kidd et al ,  
1995; Collo et al ,  1996; Vulchanova et al ,  1996; Vulchanova et al ,  1997) but 
functional evidence may have to wait until the discovery of potent subunit 
selective antagonists. A summary of the seven known P2X receptor subtypes is 
shown in table 1 .
Î
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Receptor Tissue (functional 
assay)
Agonist Profile Suramin
sensitive
P2Xi Rat vas deferens ATP = 2MeSATP = a,pMeATP Yes
Human HL60 cells a,pMeATP > ATP = 2MeSATP Yes
P2X2 Rat PC 12 cells ATP > 2MeSATP »  a,pMeATP Yes
Rat vagal preganglionic 
neurones
ATP »  a,pMeATP Yes
P2X3 Rat dorsal root ganglion 2MeSATP > ATP > a,pMeATP Yes
P2 X4 Rat submandibular 
epithelial cells
ATP »  a,pMeATP No
P2 X 5 Rat trigeminal 
mesencephalic nucleus 
neurones
ATP »  a,pMeATP Yes
P2 X6 Rat brain ATP > 2MeSATP > ADP No
P2X? Mouse microglila 
NTW - 8  cells
BzATP > ATP > 2MeSATP »  
a,pMeATP
No
Table 1. Summary of laiowii endogenous P2X receptor subtypes, their 
localisation and pharmacological characteristics.
17
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A special feature of the PZX? receptor is its sensitivity to changes in pH, with 
maximum responses to ATP at pH 6.5 when expressed in oocytes (King et ai,  
1996). The heteromeric P2 X2/P2 X3 receptor is also sensitive to changes in pH 
and it has been shown that various nociceptive substances potentiate ATP 
responses at this receptor (Wildman et al ,  1997). The P2X] receptor is 
expressed only in sensory neurones (Chen et al ,  1995), whereas the P2 X4 
receptor is widely expressed in many central and peripheral tissues (Bo et al ,  
1995; Buell et al ,  1996). It is interesting to note that the P2 X4 receptor in the rat 
is not sensitive to the classical ATP antagonists suramin, reactive blue 2 and 
pyridoxalphosphate-6-azo-phenyl-2’,4’-disulphuric acid (PPADS), and indeed 
responses are even potentiated (Bo et al ,  1995). Human P2 X4 receptors seem to 
have a higher sensitivity to blockade by suramin and PPADS (Garcia-Guzman et 
al,  1997). This along with the fact that the originally proposed P2X receptors 
selective agonist apMeATP is not effective at all P2X subtypes (see table 1) 
raises the possibility that those receptors that are insensitive to a[3MeATP and 
suramin may have been overlooked. It may also mean that novel responses 
mediated by P2X receptors remain to be discovered.
P2Y receptors.
P2Y receptors are G-protein coupled and typically have seven transmembrane 
domains which are well conserved, an extracellular N-terminus and an 
intracellular C-terminus which are more variable in structure. Binding sites have 
been identified on the 6 *^' and 7^*^ transmembrane domains (Barnard et al ,  1994).
18
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To date, five mammalian P2Y receptors have been cloned and termed P2Yi, 
P2 Yz, P2 Y4 , P2 Y6 receptors and a recently identified receptor that has been 
termed P2Yu (Webb et al ,  1993; Lustig et al ,  1993; Commimi et al ,  1995; 
Nguyen et al ,  1995; Chang et a l ,  1995; Communi et al ,  1997). All the 
mammalian P2Y receptors cloned to date activate phospholipase C. The P2Yn 
receptor has been shown to activate adenylate cyclase as well as phospholipase C 
(Communi et al ,  1997). It is likely that other members of the P2Y receptor 
family exist, such as the P2Y? receptor proposed following cloning from human 
erythroleukemia cells (Akbar et al ,  1996). However, it was later decided that this 
receptor should not be classified as a P2Y receptor as, although it has a 30% 
identity to the human P2Yô receptor, if  s primary response is to leukotriene B4 
(Yokomizo et al ,  1997). The p2y5 receptor (Webb et al ,  1996) was identified 
from chicken by a specific nucleotide binding series. It is designated in lower 
case because no functional response to nucleotides has been described.
The resolution of P2Y receptor subtypes is hampered due to the lack of subtype 
selective agonists and antagonists. In addition, the agonist selectivity of P2Y 
receptors is difficult to establish due to the presence of ecto-enzymes that 
metabolise and interconvert nucleotides (Zimmerman, 1996). The P2Y| receptor 
is the only receptor for which progress has been made in developing synthetic 
selective agonists and antagonists. 2-methylthioADP is an agonist with low 
nanomolar potency at the P2Yi receptor that does not activate the P2Y], P2 Y4 or 
P2Y6 receptor. Suramin and reactive blue 2 exhibit low selectivity among P2 
subtypes. Suramin is an antagonist at both P2Y, and P2Y] receptors (Charlton et 
al,  1996). PPADS competitively antagonises the P2Yi and P2 Y4 receptors but is
in troduction
inactive at the P2 Y2 receptor (Communi et al ,  1996; Charlton et al ,  1996). 
Adenosine 3’,5’-bisphosphate has recently been introduced as a relatively high 
affinity P2Yi receptor antagonist that does not interact with the other P2Y 
receptors (Boyer et al ,  1996). A summary of the cloned mammalian P2Y 
receptors is given in table 2 .
Receptor Localisation Agonist profile
P2Y, Brain, placenta, prostate 
and ovary
2MeSATP > ADP > ATPyS > a,PMeATP
P2Y2 Lung, bone, pituitary UTP > ATP »  2MeSATP = a,(3MeATP
P2Y4 Placenta, brain. UTP »  UDP > ATP
P2Y6 Aorta smooth muscle, 
spleen, placenta
UDP »  UTP > ATP
P2Yn Spleen, granulocytes ATP > 2MeSATP »  ADP
Table 2. Summary of loiown endogenous P2Y receptor subtypes, their 
localisation and pharmacological characteristics.
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IV. Diadenosine polyphosphates.
Diadenosine polyphosphates, or adenine dinucleotides, consist of two adenosine '4'
-f.
molecules linked at their 5’ region by a chain of 2-6 phosphate groups. The f
whole group is abbreviated to Ap^A, where n indicates the number of phosphates 
in the connecting chain. The first demonstration that diadenosine 
polyphosphates could influence tissue function was shown in smooth muscle y
preparations (Stone, 1981a) where they induced contraction. The discovery of 
Ap4A, ApsA, and ApeA in neurosecretory granules, co-stored with 
catecholamines or acetylcholine and ATP, enlarged their role to the nervous 
system (Pintor et al,  1992,1992a). Upon release into the extracellular space, the 
dinucleotides may act as uncleaved molecules on a variety of target cells via 
purinergic receptors. However, they can also be cleaved by extracellular 
phosphodiesterases and ectoenzymes to ATP, ADP and finally adenosine. In the 
hippocampus, dinucleotides have been shown to depress postsynaptic field 
potentials and intracellularly recorded postsynaptic currents (Klishin et al.,
1994). However, increases in intracellular calcium levels have also been 
demonstrated in the hippocampus (Panchenko et al ,  1993), deermouse brain 
(Pintor, 1993), and midbrain synaptosomes (Pintor et al,  1995).
Receptors for diadenosine polyphosphates.
Debate exists surrounding the receptors activated by diadenosine |
polyphosphates. Evidence exists for the activation of P2X (Hoyle et al ,  1989),
P2Y (Castro et al ,  1990) and PI receptors (Klishin et al ,  1994). The
i
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dinucleotides may even act on a distinct subtype of P2 receptor. Displacement
V. Adenosine.
(see Stone et a l ,  1991 for review).
. a
studies using [^^S]ADP4A and competition studies looking at displacement of ;
[^^S]ADP-p-S by adenosine polyphosphates in rat brain synaptic terminals found ;
a binding profile which was distinct from previous P2 receptors and had a high
affinity for diadenosine polyphosphates (Pintor et al ,  1993). This receptor was
termed P2j or P4 (Pintor et al ,  1995), however it is now considered part of the
P2Y receptor family although the receptor has not been cloned.
In 1970, Sattin & Rail described the first evidence for the receptor-mediated 
effects of adenosine. Since then, adenosine has become established as an 
important neuromodulator in the peripheral and central nervous system.
Adenosine can be synthesised intracellularly de novo and transported across the 
cell membrane to exert its extracellular effects or alternatively, adenosine can be
■formed from the metabolism of adenine nucleotides in the extracellular space
Adenosine Receptors
IAdenosine acts on four well-defined G protein-coupled receptors. These are 
called Al, A2A, A2B and A3 receptors and have been collectively termed PI 
receptors (Burnstock, 1978). The four receptors have been cloned from several 
mammalian species including man (see below). Although pharmacological data
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exist suggesting the presence of undiscovered adenosine receptors (Cornfield et 
al,  1992, Johansson et al ,  1993, Johansson & Fredholm, 1995, Cunha et al ,
1996, Lindstrom et al ,  1996), the cloning efforts of several laboratories have 
shown no evidence of this. One of the aberrant sites (a putative “A4 ” receptor) 
was suggested to represent binding to a state of the A2A receptor (Luthin &
Linden, 1995). There is evidence in the case of the adenosine A, receptor that, as 
well as the traditional agonist site an allosteric site exists that regulates its agonist 
binding and biological effects (Bruns & Fergus, 1990; Bruns et al ,  1990;
Mundumbi et al ,  1993; Leung et al ,  1995). Supporting this, the allosteric 
enhancer PD81723 has been shown to stabilise the adenosine A| receptors 
coupling to G-proteins.
Adenosine receptors were originally classified according to their actions on 
adenylate cyclase (Van Calker et al ,  1979), adenosine Ai receptor activation T
inhibiting the enzyme to decrease cyclic AMP levels and adenosine A2A receptor 
activation stimulating it. These effects on adenylate cyclase are mediated through 
the activation of G-proteins namely G[ or Go for Ai receptors (Munshi & Linden,
1989; Munshi et al ,  1991) and Gs for A2 receptors (Morgan, 1991). This ;
classification has been superseded since it has been shown that there is a plethora T
of effects mediated by both subtypes which are known not to involve adenylate
cyclase. Below, the characteristics of the individual adenosine receptor subtypes
will be discussed. ;
23
in troduction
Adenosine Ai receptors
Adenosine A] receptors have been cloned from a variety of mammals including 
man (Libert et ai ,  1992; Townsend-Nicholson & Slrrine, 1992), rat (Mahan et 
ai,  1991), mouse (Marquardt et ai ,  1994), dog (Libert et al ,  1991), cow (Tucker 
et al. 1992) and rabbit (Hill et al, 1997). Using Northern blot in the rat r
Ipreparation Stehle et al (1992) showed the receptors to be distributed in the 
following descending order of density:
Brain (cortex, hippocampus, cerebellum > ventral midbrain, pons, hypothalaiuus 
> striatum) = spinal cord > fat > testis > uterus > heart > kidney »  skeletal 
muscle, liver, intestine, stomach.
Their function in the body include depression of heart rate (Olsson & Pearson,
1990), inhibition of lipolysis (Fredholm, 1985), inlribition of neurotransmission :!■
in brain slices (Stone, 1991) and vas deferens (Hedqvist & Fredholm, 1976).
Several selective agonists and antagonists are available for the A| receptor.
These include the agonists, 2-ehloro-N^-cyclopentyladenosine (CCPA) > N^- 
cyclopentyladenosine (CPA) > N^-cyclohexyladenosine (CHA) ^ (R)-N^-
phenylisopropyladenosine (R-PIA) > (adenosine-5’-N-ethyluronamide (NECA). y
•i:
Antagonists for this receptor include the xanthine compounds 8-cyclopentyl-l,3- 
dipropylxanthine (DPCPX) and 8 -phenyltheophylline (8 -PT) and also the non- 
xanthine compound, WRC0571 (Martin et al ,  1996). f
As previously mentioned, adenosine A] receptors can couple to all Gj and Go 
proteins (Munshi & Linden, 1989; Munshi et al ,  1991) to inhibit adenylate
2 4
in troduction il 
.cyclase. However, activation of these receptors can also lead to phospholipase C 
and D activation (see Fredliolm et al ,  1995), and protein kinase activation 
(Gerwins & Fredholm, 1995) opening of K channels (which can inhibit neuronal 
firing) (Okada & Ozawa, 1980; Segal. 1982; Trussel & Jackson, 1985) and 
blockage of N-, P- and Q-type Ca channels (to inhibit transmitter release)
(Dolphin e ta l ,  1986; Schubert a/,, 1987).
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Adenosine Â2a receptors
Adenosine Aia receptors have been cloned from human, rat and mouse cells 
(Marquardt et ai ,  1994; Chu et al., 1996; Peterfreund et al ,  1996). In the brain,
A2a receptors are mainly localised in the striatum, however autoradiographic
binding studies have shown they exist in the hippocampus as well (Cunha et a l ,
1994a), usually closely associated with A; receptors. A%A receptors have also
been shown in platelets, neutrophil leukocytes, endothelium and lymphocytes 
.(Ongini & Fredholm, 1996). They exert their effects through Os and G|g 
stimulation of adenylate cyclase (Gudermann et al, 1997) and also through 
stimulation of phospholipase C. Thus, in cells that express abundant AiA 
receptors it is reasonable to assume that adenosine, acting via this receptor, can 
increase intracellular coneentrations of calcium ions [Ca^^],.
In vivo, adenosine A jA receptor functions include regulation of sensorimotor 
integration in the basal ganglia (Ferré et al, 1992), inhibition of platelet 
aggregation (Dionisotti et al ,  1992), inhibition of oxidative burst in 
polymorphonuclear leukocytes (Cronstein, 1994) and coronary vasodilation 
(Olsson & Pearson, 1990). Selective agonists and antagonists are available for
'Î
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the adenosine Aia receptor. The agonist 2-[p-(carboxyethyl)-phenyiethylamino]“ 
5’-N-ethyicarboxamidoadenosine (CGS 21680) is 70-140 fold selective for Aia 
over A] receptors (Williams, 1991). Other A jA receptor agonists include, 
adenosine-5’-N-ethyluronamide (NECA), and its derivatives APEC, PAPA- 
APEC and HE-NECA (Barrington et ai ,  1989; Cristalli et al., 1992), and several 
2-alkoxyadenosines (Ukena et al ,  1991). Antagonists for A iA receptors inelude 
4-(2-[7-amino-2-{2-furyl}{l,2,4}triazolo{2,3-a}{l,3,5}triazin-5-yl- 
amino]ethyl)phenol (ZM 241385) (Poucher et al,  1995), 4-amino-8-chloro-l- 
phenyl(l,2,4)triazolo(4,3a)quinoxaline (CP 66713) and chlorostyryl-caffeine 
(CSC).
Adenosine Aib receptors.
These receptors have been cloned from human, rat and mouse (Pierce et al ,  
1992; Stehle et al ,  1992; Marquait et al ,  1994) but are less well characterised 
than the Ai or A%A receptors, mainly due to the lack of selective pharmacological 
tools available. No selective agonists are available, although alloxazine has been 
shown to be a slightly selective antagonist (Brackett & Daly, 1994). The 
transduction mechanisms of Aib receptors include activation of adenylate cyclase 
and mobilisation of calcium ions via phospholipase C.
AiB receptors are mainly found in the large intestine, bladder, lung and brain 
although PCR reveals low amounts in practically all cells. Their tissue functions 
include release of inflammatory mediators and relaxation of smooth muscle.
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Selective agonists and antagonists have become available which will help 
characterise these receptors further. The first agonist available was N‘^ -(3- 
iodobenzyl)-adenosine-5’“N“methyIuronamide (IB-MECA), which is 
approximately 50-fold selective in binding assays for rat A3 versus either Ai or 
A2A receptors (Kim et al ,  1994). The 2 -substituted analogue of this compound 
(2C1-IB-MECA) is 2500- and 1400-fold selective for rat A3 versus A] and AiA 
receptors respectively (Jacobson, 1998). Antagonists for the A3 receptor have 
been introduced only recently. The dihydropyridine and triazoquinazoline
2 7
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Adenosine A3 receptors.
The latest adenosine receptor to be discovered is the A3 receptor. It was first 
cloned from rat (Zhou et al ,  1992) and then later from sheep (Linden et al,
1993) and man (Salvatore et al ,  1993). The cloned receptor from all three 
species was able to cause inhibition of adenylate cyclase, in addition A3 receptors 
have been shown to activate phospholipase C (Ramkunar et al ,  1993) and a 
more sustained activation of phospholipase D (Ali el al ,  1996) leading to 
activation of protein kinase C.
In humans, A3 receptors are found in the lungs, liver, heart and kidneys, with a 
lower density being found in the brain and testes (Linden, 1994). The 
concentration of endogenous adenosine required to activate A3 receptors is 
higher than that required to activate either Ai or A2A receptors. High 
concentrations of adenosine occur during hypoxic stress and other cellular 
damage, so that the role of the A3 receptor may be as an endogenous regulator %
■ :i
under conditions of severe challenge.
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derivatives, MRS 1191 and MRS 1220 have proved the most useful (Jiang e( ai,
1996; Kim et ai ,  1996), although significant species differences exist.
Interactions between adenosine receptors.
Many cells express more that one type of adenosine receptor. For example, in 
the hippocampus, adenosine A%A receptor messenger RNA expression is mainly 
localised in the pyramidal and granular cells, the same regions that show 
adenosine Ai receptor messenger RNA expression (Cunha et ai ,  1994a).
Adenosine Ai and Aia receptors have also been shown to be co-localised in the 
striatum and cortex. In these areas it has been shown that activation of 
adenosine Aia receptors attenuates the inliihitory effects of adenosine A| 
receptor activation (Cunlia et al,  1994a, Dixon et al ,  1997, Lopes et al ,  1999).
Adenosine A3 receptors have also been shown to produce a desensitisation of A| 
receptors in the rat hippocampus through a mechanism involving protein kinase 
C (Dunwiddie et al ,  1997).
I
VI. 5’ adenylic acid deaminase studies.
Adenylic acid deaminase (AMP aminohydrolase, AMP deaminase, AMPase,
B.C.3.5.4.6 .) catalyses the hydrolytic cleavage of adenosine monophosphate
,,,,
(AMP) to inosine monophosphate (IMP) and ammonia. It is found in a variety of 
eukaryotes, including mammals, birds, amphibians (Zielke & Suelter, 1971), 
plants (Turner & Turner, 1961) and yeast (Yoshino et al ,  1979). The enzyme
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has been proposed to play a role in the regulation of adenylate energy 
metabolism (Yoshino & Murakami, 1981), in the control of the purine nucleotide 
cycle (Lowenstein, 1972) and in regulation of phosphofructokinase (Yoshino & 
Murakami, 1982).
Earlier studies in this laboratory involving the use of AMPase to inhibit the 
effects of AMP on epileptiform activity in hippocampal slices revealed a gradual 
decline in activity rate during washout of 0.2 U/ml AMPase. This depression of 
activity persisted for up to 90 min (Ross, 1997). Following this report of long­
term depression of hippocampal firing, it was decided to investigate further the 
effects of AMPase on evoked responses in the CAl area of rat hippocampus.
The effects of AMPase on hippocampal plasticity were of interest following 
reports that levels of the enzyme are elevated in the brains of Alzheimer’s 
disease patients (Sims et al ,  1997), a condition intrinsically associated with 
learning and memory abnormalities. Further, activity of the enzyme increases 
with age (Zoref-Shani et a l ,  1995). These observations provided a tantalising 
possibility that AMPase may act as a modulator of the mechanisms involved in 
learning and memory in the mammalian brain.
Chapter 5 describes the attempts to characterise the depressant effects of 
AMPase and the subsequent discovery that a protein contaminant of the enzyme 
preparation was, in fact, the active factor involved- not the AMPase molecule. 
Results from the purification, sequencing and subsequent attempts to identify this 
unlmown protein are described.
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CHAPTER 2. 
MATERIALS AND METHODS.
L Preparation of hippocampal slices.
Male Wistar rats (150-200g) were anaesthetised with intraperitoneal urethane 
(1.5g\kg). The animals were then killed by cervical dislocation, decapitated 
using a guillotine, and the brain rapidly removed to ice-cold artificial 
cerebrospinal fluid (aCSF). In some instances the animals were cooled on ice 
whilst breathing oxygen emiched air following administration of urethane, until 
rectal temperature reached 30 "C. This procedure was recommended by Newman 
et al ,  (1992) to enlrance the viability of slices. However, in these studies no 
obvious difference was observed between the viability of slices from cooled
versus uncooled animals.
k
Following removal, the brain was placed in a Alter paper lined petri dish and
completely submerged in the ice-cold gassed aCSF. The cerebellum was
removed and the cerebral hemispheres separated using a scalpel blade. The
hippoeampi were then dissected free of surrounding tissue using spatulas and cut I
transversely into slices 450 pm thick using a Mcllwain tissue chopper. The slices
were separated using sealed glass micropipettes and transferred to another petri
dish where freshly gassed aCSF was added in sufficient quantity to just cover the
slices. The dish was placed in an incubation chamber saturated with 95% 0^/5%
CO2 and the slices maintained at room temperature for at least one hour before 
being transferred to a recording chamber.
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II. Composition of artificial cerebrospinal fluid (aCSF).
The composition of aCSF was (mmoi.F^) KH2PO4 2.2, KCl 2, NaHCOg 25, 
NaCl 115, CaCh 2.5 MgS0 4  1 . 2  and glucose 10. It was gassed with a mixture of 
95% O2 and 5% CO2 to yield a pH of 7.4. In experiments using barium, MgCh 
was substituted for MgS0 4  in order to prevent precipitation of BaS0 4 . This
modification did not have any effect on slices compared with the standard aCSF 
solution.
III. Bath superfusion and application of drugs.
Following incubation, individual slices were transferred to a 1 ml recording 
chamber using a fine brush. Care was taken to minimise physical manipulation 
of the slices. The slice was placed on a fine wire mesh and held in place using a 
thin bar formed from a blunted seeker needle mounted on a micromanipulator. 
The slice was perfused constantly from a gravity feed tlnough silicon tubing at a 
rate of 3 ml/min with gassed aCSF which had been heated in a thermostatically 
controlled water bath until the temperature in the bath was 30 °C. The flow rate 
and temperature were checked regularly to ensure consistency. Drugs were 
added to the perfusion medium and applied to the slices for a minimum of 1 0  min 
to ensure the attainment of equilibrium responses. To minimise organic growth 
in the recording chamber and in the silicon tubing, the apparatus was flushed 
with distilled water for at least one hour at the beginning and end of each day. In 
addition, the apparatus was dismantled weekly and the silicone tubing physically 
manipulated in order to dislodge any growth and both the tubing and recording
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chamber were cleaned with dilute hydrochloric acid before being rinsed 
thoroughly with distilled water.
IV. Stimulating and recording arrangements.
Figure 2.1 is a representation of the hippocampal slice showing the main 
neuronal elements of the structure and the positioning of the recording and 
stimulating electrodes.
Stimulation.
The slices were orthodromically stimulated using a concentric bipolar electrode 
(Clark Electromedical Instruments Ltd.) placed in the stratum radiatum at the
CA1/CA2 junction of the hippocampus. 1.0 FIz stimulation was used at the 
beginning of an experiment until the desired potential was found (population 
spike or EPSP), then stimulation was reduced to 20 s intervals in order to prevent 
the induction of long-term depression (LTD) in the slice. Reducing the 
stimulation frequency usually resulted in an initial depression of response which 
recovered to maximum amplitude within 20-30 min. For this reason slices were 
allowed to settle for at least 45 min before recordings of potentials were made. A 
submaximal response (70% of maximum PS amplitude) was used in all 
experiments.
Recording.
Recordings were made using borosilicate glass microelectrodes which were
created using a Kopf vertical puller. The tips of the resulting electrodes were y
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broken back to 2-4 pm under low magnification using a glass probe. The 
electrodes were filled with sodium chloride 0.9% using a fine 36 gauge needle.
Simultaneous recordings of population spikes and population excitatory 
postsynaptic potentials (popEPSPs) were made from the stratum pyramidale and 
stratum radiatum of the CAl area respectively. Only slices in which a population 
spike amplitude greater than 1 mV could be recorded were used in experiments.
Recorded signals were amplified (Neurolog), and monitored on a digital 
oscilloseope and on-line using Signal software (Cambridge Electronic Design, 
CED). In experiments where input/output relationships were examined, an 
average of five responses at a given stimulus intensity was calculated using CED 
software (Sigavg, Signal).
V. Data analysis and statistics.
Responses were quantified as the amplitude of the population spike (measured as 
the difference between peak negativity and the averaged values of the two peak 
positivities of the spike) and/or the slope of the negative arm of the population 
EPSP. For investigations of EPSP-spike coupling, input/output (I/O) curves were 
obtained by varying the stimulus intensity and plotting responses for population 
spike amplitude and population EPSP slope as a percentage of maximum control 
values against stimulation intensity. Changes in population EPSP slope and 
population spike amplitude were evaluated as differences in area under the curve
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of their respective I/O curves before and after drug addition for individual slices 
and the mean and standard error of the mean calculated. From the I/O curves, 
EPSP-spike (E-S) curves could be constructed by expressing the population spike 
amplitude as a function of population EPSP slope. The effect of drugs on the E-S 
relationship eould be evaluated by a shift in the E-S curve compared to control (a 
left shift indicates E-S potentiation whereas a right shift in the curve indicates E- 
S depression). To quantify shifts in the E-S relationship, the population spike 
amplitude seen at a population EPSP slope 70% of maximum was measured 
before and after drug addition for each slice and the values expressed as mean ± 
s.e.mean (Bernard and Wheal, 1995a,b). Alternatively, the ratio PS/EPSP was 
measured in each slice before and after drug addition to assess changes in EPSP- 
spike coupling. An increase in this ratio showed that E-S potentiation had 
occurred (Richter-Levin et a l, 1991).
In experiments measuring long-term effects of agents, the response observed 30 
min after washout of drug was taken as the cut off point from where statistical 
comparisons were made (events were considered long-term if they lasted 30 min 
or more).
A paired Student’s t-test was used to determine the degree of significance of 
responses before and after drug perfusion. Multiple comparisons involving more 
than two different sets of data were made using analysis of variance (ANOVA) 
followed by a Student-Newman-lCeul’s test. In the figures statistically significant 
differences between data are denoted with asterisks, p < 0.05 was taken to 
denote significance.
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Figure 2.1 Diagram showing the organisation o f  a hippocampal slice. The 
stimulating electrode (a) was positioned in the stratum radiatum at the CA1/CA2 
junction. Orthodromic population spikes and population excitatory postsynaptic 
potentials were recorded from the stratum pyramidale and stratum radiatum 
respectively using electrodes (h) and (c). (Adapted from Andersen ef al., 1971b)
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VL Protein purification techniques.
During the course of investigations into the effects of AMPase on hippocampal 
slices, it became apparent that the long-term depression of responses seen after 
removal of AMPase from slice preparations was not in fact due to an action of 
AMPase, but rather a contaminant in the preparation reeeived from Sigma. It 
was decided to try and identify this element. The crude protein preparation was 
purified by means of fast performance liquid chromatograpic and gel filtration 
techniques by Prof. H.G. Nimmo, University of Glasgow (see appendix 1) and 
the purified protein sequenced by Dr. N. Morrice, University of Dundee 
(appendix 2).
VII. Drugs.
The majority of drugs were made up in distilled water to form a stock solution 
and then diluted to the required concentration in aCSF. N6-cyclopentyladenosine 
(CPA), 8-phenyltheophylline (8-PT) and 8-cyclopentyl-l,3-dipropylxanthine 
(DPCPX), were dissolved in ethanol, 7-nitroindazole (7NI) and indomethacin 
were dissolved in methanol. Dimethylsulphoxide (DMSO) was used to dissolve 
4-amino-8-chloro-l-phenyl(l,2,4)-triazolo(4,3a)quinoxaline (CP 66713), 4-(2-[7- 
amino-2-{2-fury 1} {1,2,4,}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol 
(ZM 241385), forskolin, 2-[l-(3-dimethylaminoproply)indol-3~yl]-3-(indol-3- 
yl)maleimide (GF109203X), glibenclamide and 8-(3-chlorostyryl)caffeine (CSC) 
with the final concentration of DMSO never exceeding 0.1%, 5’adenylic acid
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deaminase (AMPase) and adenosine deaminase were dissolved directly in aCSF 
with AMPase being filtered to remove residue.
Adenosine, adenosine triphosphate (ATP), adenosine deaminase, 5’adenylic acid 
deaminase (AMPase), N6-cyclopentyladenosine (CPA), 8~Bromoadenosine- 
3’:5’-cyclic monophosphate (8Br cAMP), NG-nitro-L-arginine methyl ester (L~ 
NAME), 7-nitroindazole (7NI) and forskolin were obtained from Sigma 
Chemical Co. Ltd.. 2-p-(2-carboxyethy)phenethylamino-5’-N-
ethylcarboxamidoadenosine (CGS 21680), 9-(tetrahydro-2-furanyl)-9H-purin-6- 
amine (SQ 22536), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), and N-[2- 
methylamino)ethyi]-5-isoquinolinesulfonamide hydrochloride (H8) were 
obtained from Research Biochemicals International. 4-amino-8-chloro-l- 
phenyl(l,2,4)-triazolo(4,3a)quinoxaline (CP 66713) was obtained from Pfizer 
and 4-(2-[7-amino-2-{2-furyl}{ 1,2,4,}triazolo {2,3-a}{ 1,3,5 }triazin-5-yl-
amino]ethyl)phenol (ZM 241385) from Zeneca Pharmaceuticals. N-(2- 
aminoethyl)-5-chloro-1 -napthalenesulphonamide (A3 HCl), and 2-[l-(3- 
dimethylaminoproply)indol-3-yl]-3-(indol-3-yl)maleiinide (GF109203X) were 
obtained from Tocris Cookson.
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CHAPTER 3.
INTERACTIONS BETWEEN ADENOSINE Ai AND 
AzA RECEPTOR SUBTYPES.
I. Introduction.
Adenosine is a neuromodulator with both presynaptic and postsynaptic effects in 
the mammalian CNS. It has been suggested that these effects are mediated by 
different mechanisms in view of, for example, their different sensitivities to 
agents such as pertussis toxin (Fredholm et a i, 1989; Hasuo el a l, 1992; 
Thompson et a l,  1992). Presynaptically, adenosine has been shown to inhibit the 
release of neurotransmitters such as acetylcholine (Spignoli et a l, 1984), 
dopamine (Michaelis et a l, 1979; Zetterstrom and Fillenz, 1990) serotonin 
(Feuerstein et a l, 1985) and glutamate (Fastbom and Fredholm, 1985). The 
mechanism of adenosine’s presynaptic effects is not fully clear but it has been 
suggested that it causes an increase in potassium conductance which could 
hypeipolarize the axon terminal and so prevent transmitter release (Thompson et 
a l, 1992). Supporting this, it has been shown that channel blockers such as
4-aminopyridine can reduce the effects of adenosine (Stone, 1981). An indirect 
decrease of calcium currents or intracellular calcium levels by this adenosine 
activated potassium conductance has also been suggested as a mechanism of 
presynaptic inhibition (Dunwiddie and Haas, 1985; Michaelis et a l, 1988).
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Alternatively, adenosine may exert its presynaptic effects by inhibiting calcium 
influx directly (Dolphin et a l, 1986; Schubert et a l, 1987).
Postsynaptically, the mechanism of action of adenosine is elearer. Several groups 
have suggested that adenosine causes an increase in outward potassium 
conductance leading to a hyperpolarisation of the postsynaptic membrane (Okada 
and Ozawa, 1980; Segal, 1982; Trussel and Jackson, 1985). This potassium 
conductance has been shown to be both calcium and voltage insensitive in CAl 
neurones (Gerber et a l, 1989).
Earlier studies have suggested that the inliihitory presynaptic actions and 
postsynaptic hyperpolarising actions of adenosine are mediated by A] receptors 
(Dunwiddie and Fredholm, 1989; Alzheimer et a l, 1991; Ameri and Jurna, 1991 ; 
Lambert and Teyler, 1991; Hasuo et al., 1992) which are present in high density 
in the hippocampus, especially in the CAl region (Fastbom et a l, 1987). 
Electrophysiological (Sebastiao and Ribeiro, 1992) and binding (Jarvis et a l, 
1989; Cunha et a l, 1994a) studies have shown that adenosine Aia receptors are 
also present in the hippocampus but conflicting reports exist as to the functional 
importance of these receptors and their ability to interact with Ai receptors. 
Cunlia et a l, (1994a) describe an attenuation of the inliihitory effects on 
population spike amplitude caused by activation of Ai adenosine receptors with 
N^“Cyclopentyladenosine (CPA) in the presence of the selective A%A adenosine 
receptor agonist 2-p-(2-carboxyethy)phenethylamino-5’-N-
ethylcarboxamidoadenosine (CGS 21680) in the rat hippocampus. In contrast, 
Dunwiddie et a l, (1997) report that pre-treatment of hippocampal slices with
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CGS 21680 had no effect on subsequent responses to adenosine. Recently, 
Dixon et al. (1997) have shown the appearance of a low-affinity binding site for 
the Al receptor agonist 2-chloro-N-6-cyclopentyladenosine (CCPA) in the rat 
striatum caused by incubation of striatal synaptosomes with CGS 21680.
Although the aforementioned pre- and postsynaptic effects of adenosine have 
been well characterised, little work has been carried out with regard to the effects 
of adenosine on the coupling between the two. This study investigates the effects 
of adenosine receptor agonists and antagonists on the population excitatory 
postsynaptic potential, the population spike, and the relationship between the two 
i.e. EPSP-spike (E-S) coupling. The population excitatory postsynaptic potential 
(popEPSP) gives primarily a measure of membrane potential ehanges generated 
by excitatory synapses on the apical dendrites of CAl pyramidal neurones. This 
extracellularly recorded potential has been shown to be affected by adenosine in 
the same way as intracellularly recorded EPSPs from the same cells (Proctor and 
Dunwiddie, 1983). The population spike (PS) reflects the summated firing of 
CAl pyramidal neurones (Andersen et a l, 1971) and gives a measure of the 
excitability of the postsynaptic neurone. E-S coupling gives an indication of the 
ability of a given level of synaptic depolarisation to induce the postsynaptic cell 
to fire an action potential. The three parameters measured can vary 
independently, and a description of all three is necessary to provide a full analysis 
of agents on neuronal function.
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n .  Results
Adenosine
A 10 min perfusion of adenosine 20 pM resulted in a decrease of both population 
spike (PS) amplitude and EPSP slope, but PS amplitude was reduced to a greater 
extent than EPSP slope. The relationship between stimulation strength and PS 
amplitude, EPSP slope and the corresponding E-S curve are summarised for a 
typical slice in Figure 3.1. Following the addition of adenosine in this slice the 
E-S relationship is shifted to the right as a result of the greater depression of PS 
amplitude compared with EPSP slope. From the population of slices examined, 
adenosine at 50 pM decreased both the population EPSP slope and PS amplitude 
significantly (n = 5, 40.9% ± 4.1, p < 0.01 and 65.5% ± 12.7, p < 0.001, 
respectively) (Figure 3.2a). At the lower concentration of 20pM, adenosine also 
decreased these potentials to a significant degree (n = 5, 28.6% ± 11.1, p < 0.05 
and 48.8% ± 13.0, p < 0.01, respectively) (Figure 3.2a). In each case the PS 
amplitude was reduced by a greater extent than can be accounted for by the 
decrease in population EPSP slope, resulting in a shift in the E-S curve of 24.7% 
± 10.2 (p < 0.05) with adenosine 20 pM and 43.5% ±15.1 with adenosine 50 pM 
(p < 0.05) Figure 3.2b)
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Figure 3.1. Graphs (a) and (b) show input/output curves for population spike 
amplitude and EPSP slope respectively for a single slice. In graph (c), population 
spike size is plotted as a function of EPSP slope showing the resulting EPSP- 
spike relationship. When adenosine 20pM was perfused, population spike 
amplitude was reduced by a greater extent than EPSP slope. This resulted in a 
ehange in the EPSP-spike relationship characterised by a right-shift from control 
values as seen in graph (c).
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Figure 3.2. Pooled data from n=5 slices. Chart (a) shows the effects of adenosine 
(AD) 50|iM and 20|.lM on population spike (PS) amplitude and population EPSP 
slope (popEPSP). It can be seen that perfusion of adenosine caused a 
concentration-dependent decrease in PS amplitude and EPSP slope. The 
decrease in PS amplitude was larger then could be accounted for by the decrease 
in EPSP slope resulting in a shift in the EPSP-spike relationship from control 
values (b). * p < 0.05, p < 0.01, *** P < 0.001.
4 3
A d e n o sin e  A i/A? in te rac tions
Selective agonists and antagonists
Representative potentials showing the effect of the selective adenosine A| agonist 
N^-cyclopentyladenosine (CPA) 50 nM on population spike and population 
EPSP are displayed in figure 3.3. CPA caused a significant decrease in both the 
population EPSP slope and PS amplitude (Figure 3.4, 3.5a). Input/output data 
quantify this decrease as 28.9% ± 7.9, n = 5, p < 0.01 for population EPSP slope 
and 83.9% ± 5.2, n = 5, p < 0.001 for PS amplitude. This resulted in a large shift 
to the right of the E-S curve of 81.8 % ± 5.2 (p < 0.001) (Figure 3.5b).
To ensure that CPA was exerting its effects on population EPSP slope as a result 
of decreased transmitter release and not due to an influence on presynaptic 
afferent excitability, the slope of the presynaptic volley was also measured in 
three experiments and was plotted as a function of stimulus intensity in the same 
manner as input/output curves (Figure 3.6). No change was observed in 
presynaptic afferent excitability with CPA, showing its effects are restricted to 
events occuring subsequent to the arrival of the fibre volley at the stratum 
radiatum axon terminals.
The selective adenosine Aia agonist 2-[p-(carboxyethyl)-phenylethylamino]-5’- 
N-ethylcarboxamidoadenosine (CGS 21680) 30 nM (n =" 5) and 100 iiM (n -  4) 
had no significant effects on population EPSP slope, PS amplitude or the 
relationship between the two (Figure 3.5). Similarly the Aia antagonists 4-(2-[7- 
amino-2-{ 2-fury 1} {1,2,4,}triazolo{2,3-a} {1,3,5 }triazin-5-y 1-amino] ethyl)phenol 
(ZM 241385, 50 nM) and 4-amino-8-chloro-l-phenyl( 1,2,4)-
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triazolo(4,3a)quinoxaline (CP 66713, 10 qM) also showed no significant effects 
on the three parameters, although ZM 241385 showed a tendency to increase all 
tlmee (Figure 3.5a,b).
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Figure 3.3. The effect of CPA 50 nM on population spike (PS) amplitude and 
EPSP slope (arrow). The traces show responses recorded from a single slice. It 
can be seen that a 10 min perfusion of 50 nM CPA decreased PS amplitude by a 
greater extent then EPSP slope.
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Figure 3.4. The effect of N^-cyclopentyladenosine (CPA) on PS amplitude 
(filled circles) and EPSP slope (open triangles). 10 min perfusion of CPA 50 nM 
resulted in a greater inliibition of PS amplitude than EPSP slope, resulting in a 
dissociation of the EPSP-spike relationship which returned to control values 
following 30 min washout.
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Figure 3.5 The effects of adenosine agonists and antagonists on input/output 
curves (a) and corresponding E-S curves (b). The Ai agonist CPA decreased 
both EPSP slopes and PS amplitude, and shifted the E-S curve significantly to the 
right whereas A2A receptor activation had no significant effects on any of the 
tluee parameters. ^*p<0.01,** ' ‘*p< 0.001.
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Figure 3.6 The effect of the selective adenosine Ai agonist CPA on afferent 
fibre volley. The slope of the afferent fibre volley was plotted as a function of 
stimulus intensity. It can be seen that CPA had no effect on the afferent volley.
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A i/A 2 interactions
When adenosine A| and A%A receptors were activated at the same time using 
CPA and CGS 21680 respectively, there was a reduction in the effects of CPA on 
population EPSP slope and PS amplitude. This can clearly be seen when Figure 
3.7 is compared with Figure 3.3.
Perfusion of CGS 21680 30 nM for 10 min prior to and during CPA perfusion 
caused an attenuation in the reduction of PS amplitude seen with CPA alone, 
resulting in a reduction in the amount of E-S dissociation at a stimulus intensity 
70% of maximum control (Figure 3.8).
Over a range of stimulation intensities, input/output data show CGS 21680 at 
both 30 nM and 100 nM caused a non-significant concentration related reduction 
in the effect of CPA 50 nM on PS amplitude (Figure 3.9a). Using 30 nM CGS 
21680, the inliibition of PS amplitude was reduced from 83.9% ± 4.3 to 59.9% ± 
6.5 (p < 0.05). The attenuation of the inhibition of PS amplitude by CPA 
resulted in a significant reduction in the effects of CPA on E-S coupling (p < 0.05 
using CGS 21680 100 iiM and p < 0.01 using CGS 21680 30 nM) (Figure 3.9b).
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Figure 3.7. The effect of co-activation of adenosine A, and A2A receptors with 
the selective Ai and A%A agonists CPA 50 iiM and CGS 21680 30 nM. The 
inhibition of PS amplitude by CPA was attenuated when A2A receptors were 
activated at the same time using CGS 21680.
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Figure 3.8. Activating adenosine A jA receptors with CGS 21680 30 nM 10 min 
prior to and during activation of adenosine Ai receptors using CPA 50 nM 
reduced the inliibitory effect of adenosine Ai receptor activation alone and 
prevented the dissociation of the EPSP-spike relationship seen upon activation of 
adenosine Ai receptors with CPA alone.
51
A d e n o sin e  A ./A? in te rac tio n s
9 0  -,
^  60  -
5 0  -
o
popEPSPPS
CPA50nM CRASOnM+ +CPA50nM
90  
80  
70  
60  
50  
40  
30  
20 
1 0 
0
////
C G S 2 1 5 8 0  C GS 2 1 6 8 0
30nM lOOnM
CPA CPA50nM CPASOnM
5 0 n M + +CGS21 6 8 0  C GS 2 16 8 0
30nW lOOnM
Figure 3,9, Pooled data (n=5) showing the effects of co-activation of Ai and 
A2a receptors with selective agonists. Addition of the adenosine A2A receptor 
agonist CGS 21680 caused a significant reduction in the inhibition of population 
spike amplitude seen upon Ai receptor activation alone (a). Addition of either 30 
nM or 100 iiM CGS 21680 resulted in a significant reduction in the right shift of 
the E-S curve seen upon Ai receptor activation (b). ** p<0.01, *** p<0.001 
compared with controls. # p<0.05, ## p<0.01 between columns.
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Transduction modulators.
In an attempt to determine the mechanism by which A2A receptor activation 
attenuated A 1-mediated responses, the role of various second messengers and 
nitric oxide was investigated. The membrane permeable analogue of cAMP: 8- 
Bromoadenosine-3’;5’-cyclic monophosphate (8Br cAMP; lOOpM, n=3) by itself 
decreased PS amplitudes but had no effect on the inhibition of popEPSP slope 
nor PS amplitude seen with CPA superfiision when used in combination with this 
agent. 8Br cAMP itself had no effects on the E-S curve and furthermore, had no 
significant effect on the magnitude of the shift obtained with CPA when the two 
compounds were added together (Table 3).
The adenylate cyclase activator forskolin (lOpM, n=3) decreased both popEPSP 
slopes and PS amplitudes and caused a right-shift in the E-S curve (Table 3) but 
again no change was seen in CPA-mediated responses when in the presence of 
forskolin (Table 3). In contrast the adenylate cyclase inhibitor 9-(tetrahydro-2- 
furanyl)-9H-purin-6-amine (SQ 22536; lOpM, n=3) had no significant effects on 
I/O curves nor E-S coupling by itself, although when tested in combination with 
CPA it did not affect the inliibitory responses seen with CPA alone (Table 3). 
These results suggest that the adenylate cyclase/cyclic AMP system is not 
involved in the A2A attenuation of A i-mediated inhibitory responses.
To investigate the role of second messengers further downstream in the signal
t
Itransduction process the effects of protein kinase inhibitors was investigated.
.The hydrochloride salt of the general protein kinase inliibitor N-(2-aminoethyl)-
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5-chloro-l-napthalenesulphonamide (A3 HCl; lOpM, n=4) had no significant 
effect on popEPSP slopes, PS amplitudes nor the coupling between the two, nor 
did it affect the inhibition mediated by CPA when added in combination (Table 
3, Figure 3.10). 2-[l-(3-dimethylaminoproply)indol-3-yl]-3-(indoF3"
yl)maleimide (GF109203X; lOOnM, n=5) is a veiy potent and selective inliibitor 
of protein kinase C (Toullec et a l, 1991). Addition of this compound to the 
superfusing medium resulted in a decrease of PS amplitude, but no resulting shift 
in E-S relationship (Table 3). GF 109203X also had no effects on the adenosine 
AiA-recGptor mediated attenuation of At inhibition of responses (figine 3.12) 
Neither was the inhibitory effect of CPA affected by addition of this compound 
(Table 3). The protein kinase A inhibitor N-[2-methylamino)ethyl]-5- 
isoquinolinesulfonamide hydrochloride (H8; 30pM, n=4) had no significant 
effects on I/O curves or E-S coupling. Again this compound also had no effect 
on the inhibitory action of CPA (Table 1).
Nitric oxide.
To test whether nitric oxide was playing a part in the inliibition observed with A| 
receptor activation by CPA, the effects of nitric oxide synthase inliibitors were 
examined. Neither the competitive inhibitor N^-nitro-L-argiiiiiie methyl ester (L- 
NAME; 20pM, n~4) nor the selective inhibitor of brain nitric oxide synthase 7- 
nitroindazole (7NI; 40pM, n=5) had any significant effects on popEPSP slopes, 
PS amplitudes or E-S coupling, nor did they have any effects on the responses to 
CPA (Table 3).
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Figure 3.10. The effect of the general protein kinase inhibitor A3 10 pM on 
responses to CPA 50 nM
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Figure 3.11. The effect of the selective protein kinase C inhibitor GF 109203X 
on responses to CPA 50 nM.
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Figure 3.12. The effect of the protein kinase inliibitor GF 109203 on the 
inhibitory effects of adenosine A2A receptor activation on A 1-mediated 
depression of PS amplitude.
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Table 3. The effects of modulators of different transduction systems on 
population EPSP slopes (popEPSP), population spike (PS) amplitudes and E-S
coupling used both alone and in combination with N^-cyclopentyladenosine
(CPA) 50 nM. Data for N^-cyclopentyladenosine 50 nM are included for 
comparison. Statistics shown beside drugs used alone are relative to control 
values, whereas statistics displayed beside drugs when used in combination with
N^-cyclopentyladenosine 50 nM are relative to data for N^-cyclopentyladenosine 
used by itself.
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DRUG n popEPSP 
decrease %
PS
decrease %
E-S
right shift %
CPA 50 nM 5 28.9+7.9 p<0.01 83.9+4.3 p<0,001 81.8+5.2 p<0.001
SBrcAM P 100 |.iM 3 35.4+16.5 n.s. 65.8+24.7 p<0.01 27.7+27.6 n.s.
8Br cAMP 100 pM+ 
CPA 50 nM
3 48.2+12.0 n.s. 90.7+6.6 n.s. 67.1+20.9 n.s.
forskoiin 10 |_iM 3 59.4+5.5 p<0.00i 81.9+3.5 p<0.001 59.4+7.2 p<0.01
Ibrskolin 10 jaM+CPA 
50 nM
3 59.2+4.1 p<0.05 92.9+2.3 n.s. 90.1+2.2 n.s.
SQ22536 lOiaM 3 -13.4+28.2 n.s. -8.05+19.8 n.s. -13.2+6.5 n.s.
SQ22536 10 |.iM + 
CPA 50 nM
3 30.95+14.7 n.s. 81.1+8.3 n.s. 50.7+26.7 n.s.
A3 HCl lOi-iM 4 3.96+12.4 n.s. 4.3+12.8 n.s. -19.6+12.4 n.s.
A3 Hcl 10 ^iM+ 
CPA 50 nM
4 37.1+8.0 n.s. 86.9+8.0 n.s. 62.975+19.1 n.s.
GF109203X 100 nM 5 19.9+14.2 n.s. 35.2+31.1 p<0.05 9.8±9.7 n.s.
GFl 09203X 100 nM+ 
CPA 50 nM
5 32.1 + 16.2 n.s. 95.3+4.1 n.s. 78.9+9.7 n.s.
H8 30 [iU 4 -12.7+24.3 n.s. -31.7+18.5 n.s. -30.1+32.4 n.s.
H8 30 nM +CPA 50 
nM
4 26.1+14.2 n.s. 77.3+17.8 n.s. 63.9+23.4 n.s.
7-NI 40 i-iM 5 18.4+8.0 n.s. 15.9+13.8 n.s. -2.0+10.0 n.s.
7-Nl 40 \.iM+ CPA 50 
nM
5 41.7+8.7 n.s. 80.5+14.1 n.s. 73.3+17.6 n.s.
L-NAME 20 pM 4 17.5+13.5 n.s. 25.1+24.7 n.s. 2.5+5.0 n.s.
L-NAME 20 nM+ 
CPA 50 nM
4 39.9+9.5 n.s. 91.7+4.3 n.s. 89.2+5.4 n.s.
5 9
A d e n o s in e  A ,/A ? in te rac tio n s
Effect o f blocking potassium channels.
Superfusion of the potassium chamiel blockers, giibenclamide 10 pM or barium 
500pM to the slice lOmin prior to, and during, CPA 50nM perfusion, attenuated 
the inhibitory effects of CPA on PS amplitude (Figure 3.13, 3.14), again resulting 
in a significant inhibition of the E-S dissociation seen with CPA alone. The 
changes in PS/popEPSP ratio seen when adenosine A2A receptors were activated 
with CGS 21680 or when potassium channels were blocked with barium were not 
significantly different (Figure 3.15).
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Figure 3.13. The effect of blocking potassium channels with giibenclamide 10 
pM on responses to CPA.
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Figure 3.14 The effect of barium 0.5 mM on responses to CPA 50 nM.
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Figure 3.15, Comparison of the attenuation of CPA-mediated inliibitory effects 
on PS/EPSP ratio by CGS 21680 and barium.
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HI. Discussion.
The results reveal that adenosine reduces both the population EPSP slope and 
population spike amplitude in the CAl area of rat hippocampus, showing that it 
has postsynaptic actions as well as presynaptic. Consistent with previous 
findings (Dunwiddie and Fredholm, 1989; Alzheimer et a l, 1991; Lambert and 
Teyler, 1991) these effects are mediated by adenosine Ai receptors as shown by 
the fact that the selective Ai agonist N‘"*-cyclopentyladenosine produced a similar |
depression of both potentials while the Aia agonist CGS 21680 had no 
significant effects. N^^-cyclopentyladenosine caused a significantly greater shift in 
the E-S curve than adenosine, reflecting its greater effect on population spike 
amplitude combined with a lesser reduction in population EPSP slope compared 
with adenosine. This could possibly be due to a greater number of adenosine A| T
receptors at postsynaptic sites (Deckeil and Jorgensen, 1988) or a greater 
proportion of Aia receptors at postsynaptic sites which, when activated by 
adenosine cause an attenuation of the effects of A] receptor activation.
Alternatively, this difference could be explained by a more efficient uptake 
system for adenosine operating at presynaptic compared with postsynaptic sites.
E-S dissociation has previously been described as a component of long term 
potentiation in the CAl region of rat hippocampus (Andersen et a l, 1980;
Bernard and Wheal, 1995a,b). Two mechanisms have been put forward to 
explain this E-S dissociation. The first is a change in inhibitory pathways 
(Chavez-Noriega et a l, 1989; Tomasulo el a l, 1991; Tomasulo and Ramirez, A
1993) such as a modification of excitatory synapses on interneurones or changes
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in inhibitory synapses. Secondly, E-S dissociation may occur via a postsynaptic 
mechanism which alters the firing threshold of the cells (Taube and 
Schwartzlcroin, 1988; Hess and Gustafsson, 1990). It should be noted that these 
two mechanisms are not mutually exclusive. It has been suggested that 
adenosine modulates excitatory but not inhibitory synaptic transmission in the 
hippocampus (Lambert and Taylor, 1991; Yoon and Rotliman, 1991; Brundege 
and Dunwiddie, 1996) and a decrease in transmitter release here may account for 
some of its actions on the E-S relationship. However, since the population spike 
amplitude, which reflects postsynaptic excitability, decreased more than could be 
accounted for by the decrease in transmitter release it would appear that 
postsynaptic mechanisms play the major role in the decrease in E-S coupling seen 
with adenosine Ai receptor activation. This presumably results from the 
increased potassium conductance which increases the firing threshold of the cell 
(Segal, 1982; Trussed and Jackson, 1985; Thompson et a l, 1992). This 
conclusion is strongly supported by intracellular experiments, since N^- 
cyclopentyladenosine proved able to inliibit spike initiation at a concentration of 
100 nM which had little effect on resting potential (T.W. Stone, personal 
communication).
Conflicting evidence exists as to the ability of adenosine A%A receptors to interact 
with Al responses (Cunha el a l, 1994a; Dixon et a l, 1997; Dunwiddie et a l, 
1997). In this study we have seen a clear attenuation of the population spike 
response obtained following activation of adenosine A] receptors in the presence 
of the Aia agonist CGS 21680, showing there is a cross-talk between the two 
classes of receptor. Adenosine Aia receptor activation had no significant effect 
on the reduction of population EPSP slopes seen with Ai receptor activation
65
A d e n o s in e  A ,/A? in te rac tio n s
suggesting that A%A receptors interact with A, receptors selectively at 
postsynaptic sites. Previous reports suggest that adenosine A2A receptors have an 
excitatory function in the cortex (O’Regan et a l, 1992), striatum (Kirkpatrick 
and Richardson, 1993) and hippocampus (Sebastiao and Ribeiro, 1992), 
although Cunlia et al (1994a) suggest that this excitatory function is only 
apparent in the CA3 region and dentate gyrus. If this were the case here it would 
be expected that when both inhibitoiy Ai and excitatoiy A2A receptors are 
stimulated the net synaptic activity would be the result of the summation of the 
inhibitory versus excitatory mediated responses. However this seems an unlikely 
explanation since we saw no significant excitatory response with the 30 nM A2A 
receptor selective concentration of CGS 21680 used alone, but an attenuation of 
Al receptor-mediated inhibitory responses in its presence. The selectivity of this 
interaction is well illustrated by intracellular results, since CGS 21680 was able 
to prevent the suppression of spike initiation by N^-cyclopentyladenosine, in the 
absence of any significant changes of resting potential (T.W. Stone, personal 
communication).
Transduction systems.
The results obtained upon addition of agents to modify second messenger
systems suggest that the effect of A%A activation on A 1-mediated responses in the
hippocampus is independent of cyclic AMP (cAMP) and protein kinases. No
effect was found of adenylate cyclase activation with forskolin or inliibition with
. .SQ 22536 on the inhibitory effects of N -cyclopentyladenosine. Previous
.investigators have also demonstrated a lack of relationship between cAMP levels 
and the electrophysiological effects of adenosine (Reddington and Schubert,
6 6
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1979; Dunwiddie and Hoffer, 1980; Dunwiddie and Fredholm, 1984; Worley et 
a l, 1987) except in forskolin treated hippocampal slices (Fredholm et a l, 1983). 
Similarly, the general protein kinase inhibitor A3, the selective protein kinase A 
inhibitor H8  and the selective protein kinase C inliibitor GF 109203X did not 
modify sensitivity to adenosine Ai receptor activation.
There is growing evidence for an interaction between adenosine and nitric oxide 
systems (Dirnagl et a l, 1994; McKie et a l, 1994; Peralta et a l, 1997). However, 
neither the competitive nitric oxide synthase inliibitor L-NAME nor the brain 
specific inhibitor 7N1 showed any effects on the inhibition obtained upon 
addition of N 6 -cyclopentyladenosine, suggesting that nitric oxide does not play a 
significant role in the inliibition seen with Ai activation.
In contrast, blockade of potassium channels with giibenclamide or barium 
attenuated the postsynaptic actions of adenosine Al receptor activation. It is well 
established that, postsynaptically, adenosine increases potassium conductance 
(Okada and Ozawa, 1980; Segal,1982; Trussel and Jackson, 1985), and it has 
been shown that barium will selectively block the postsynaptic hyperpolarising 
effects of adenosine (Haas and Greene, 1984; Gerber at al., 1989; Thompson et 
a l, 1992; Aldioiidzadeh and Stone, 1994). In this study we have shown that the 
E-S dissociation caused by adenosine A) receptor activation studied
extracellularly, and the directly measured effect on spike threshold recorded 
intracellulaiiy (T.W. Stone, personal communication), are also prevented by 
barium. The possibility exists that a similar suppression of a potassium current
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may be the mechanism by which adenosine A2 A receptor activation causes 
inhibition of Ai receptor-mediated changes of spike tlueshold. Since barium can 
block several potassium currents (Cook, 1988; Guatteo et a/., 1998), it is not yet 
clear which of these might be involved in the A 1 /A2 A receptor interaction. It is 
unlikely that the 1a current is involved, however, as Pan et al. (1995) have shown 
that, whereas barium blocks the postsynaptic hyperpolarisation induced by 
adenosine, it does not prevent adenosine activation of the A-current. It is 
possible that an ATP-sensitive potassium channel ( K a t p )  is involved, since the 
sulphonylurea giibenclamide, which selectively blocks this type of \C  channel, 
also attenuated the postsynaptic effects of CPA. Katp channel involvement in the 
postsynaptic effect of adenosine is consistent with a report that an inhibitory 
postsynaptic potential in spinal nociceptive neurones, apparently mediated by 
adenosine, was blocked by giibenclamide (Salter et al., 1993). Adenosine 
induced hyperpolarisation has also been shown to be blocked by giibenclamide in 
the hippocampal preparation (Li and Henry, 1992).
A possible explanation for the observed A 1VA2 receptor interaction is that 
activation of the adenosine A2A receptor binding site by CGS 21680 may lead to 
a conformational change in the A% receptor and result in a decrease in the affinity 
of the receptor binding site for the Ai agonist. This process would not require a 
second messenger system. As previously mentioned, the Ai receptor has an 
allosteric binding site (Bruns and Fergus, 1990; Bruns et a l, 1990; Mundumbi et 
a l, 1993; Leung et a l, 1995). CGS 21680 may act at this site to affect the ability 
of the Al receptor to interact with its agonist or with its ability to couple to G-
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proteins. Autoradiographic studies show binding of [3H]CGS 21680 to be 
greatest in the stratum radiatum, and adenosine Ai and A2A receptors have 
previously been found together pre-synaptically at rat cholinergic nerve terminals 
(Correia-de-Sa et a l, 1991 ; Cunha et a l, 1994b). The close proximity of the two 
receptors may allow for this conformational interaction to occur. Dixon et al 
(1997) reported the appearance of a low affinity binding site for the Ai agonist 2- 
chloro-N-6 -cyclopentyladenosine following incubation of striatal synaptosomes 
with CGS 21680. This was interpreted as desensitisation by the A2A site of the 
Al receptor. Such an explanation could account for the present observations 
although the interaction reported by Dixon et al (1997) was mediated by protein 
kinase C.
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CHAPTER 4.
INDUCTION OF LTP IN THE C A l AREA OF RAT 
HIPPOCAMPUS FOLLOWING ATP PERFUSION.
I. Introduction.
The role of ATP as a transmitter or co-transmitter at neuroeffector junctions in the 
periphery is well established (Hoyle and Burnstock, 1991). The first direct evidence 
that ATP acts as a fast transmitter between neurones came in 1992 when synaptic 
currents mediated by ATP were measured in neurones cultured from guinea pig 
coeliac ganglia (Evans et a l, 1992; Silinsky et a l, 1992). These currents could be 
blocked by suramin and mimicked by ATP and a^MeATP, suggesting the 
involvement of a P2 receptor. Since then ATP receptor mediated currents have also 
been reported in intact ganglia (Silinsky and Gerzanich, 1993).
In the CNS, ATP has also been reported to act as a transmitter. It has been shown to 
produce excitation of neurones in several regions of the CNS (Harms et a l, 1992, Sun 
et a l, 1992; Tschopl et a l, 1992; Frolich et a l, 1996). Edwards et al (1992) 
provided the most direct evidence for the action of ATP as a fast neurotransmitter in 
the CNS. This group recorded evoked and miniature synaptic currents in the rat 
medial habenula and demonstrated that these currents were not affected by blockers of 
glutamate, y- aminobutyric acid (GABA) or acetylcholine receptors, but were blocked
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(Chen et a i, 1994).
glutamatergic EPSPs (Inoue et a l, 1992) to no effects on orthodromic spikes (Stone 
and Cusack, 1989) to a decrease in extracellularly measured unit spikes (Di Cori and
systems.
by suramin and the desensitising ATP analogue apMeATP. ATP has also been 
shown to modulate potassium currents in various regions of the CNS, including rat 
striatum (Ikeuchi and Nishizalci, 1995), superior colliculus (Ikeuchi et a l, 1995), '■ I.-'hippocampus (Ikeuchi et a l, 1995a) and nucleus tractus solitarii (Ueno et a l, 1992).
Calcium currents have also been shown to be modulated by ATP. For example ATP 
causes a rapid increase in intracellular calcium ions in rat hypothalamic neurones
In the hippocampus the effects of ATP receptor activation remain unclear. A range of 
effects have been described - from inward currents and increased frequency of
Henry, 1984). Several studies have shown that functional responses to adenine
nucleotides on neuronal networks and synaptic transmission in the mammalian 
hippocampus are usually explained by metabolism to adenosine (Dunwiddie and 
Hoffer, 1980; Cusack and Stone, 1989; Cunlia et a l, 1998). Receptors for ATP are 
present in the hippocampus as shown by binding studies (Michel and Humphrey, 
1993; Bo and Burnstock, 1994; Balcar et a l, 1995); messenger RNA for several P2 
receptor subtypes have also been identified in the hippocampus (Kidd et a l, 1995; 
Seguela et a l, 1996; Soto et a l, 1996). The demonstration of conductance changes 
on individual cells and coupling to second messenger pathways suggest that the 
visualised receptors are functionally coupled to channels or other transduction
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An additional piece of evidence for the role of ATP as a neurotransmitter is that it is 
released in response to tetanic (but not low frequency) stimulation (Wieraszko et a i, 
1989). This is of interest as tetanic stimulation can induce long term potentiation 
(LTP) in the hippocampus (Bliss and Lomo, 1973) and, moreover, it has been reported 
that ATP can induce LTP in mouse and guinea pig hippocampus (Wieraszko and 
Seyfried, 1989; Fujii et a l, 1995; Chen et a l, 1996).
In light of these varied and inconsistent effects ATP is reported to have in the 
hippocampus, it is the aim of this study to chai’acterise in greater detail, the effect of 
ATP on evoked potentials in the hippocampal slice preparation, using P2 purinoceptor 
agonists and antagonists.
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II. Results.
Dependence on potential size.
Slices that exhibited a population spike of 1 mV or greater were used in the study.
The induction of long-term potentiation (LTP) following perfusion with ATP seemed 
to depend on the initial size of the evoked population spike. When the maximum 
control population spike size exceeded 5 mV, no long-term potentiation was observed.
However when the maximum control potentials were less than 5 mV in size, it was 
possible to evoke long-terms potentiation quite consistently following ATP perfusion.
Figure 4.1 gives an example of such a response.
Long-term potentiation o f evoked potentials following ATP perfusion.
When low concentrations of ATP, 2.5 pM, were superfused over the slices, no 
response was apparent during the period of application, but a consistent, highly 
reproducible increase of potential size developed on washout (Fig. 4.2). This increase y
of potential size developed over approximately 1 0  min to reach a plateau level which f
was maintained for up to at least 30 min after removal of ATP. As the concentration T
of ATP was increased to 10 pM, the synaptic potentials were reduced in size during y
ATP perfusion, but the development of long-term enhancement still occurred on
washout (Fig. 4.3). The size of the ATP-induced increase of evoked potentials was f7
concentration dependent, reaching a peak of 130.9 ± 4.6% at 25 min following T
perfusion of 2.5 pM (n=3) ATP and 146.4 ± 15.9% 13 min following perfusion of 10 I:
pM ATP (n=5) compared with the control potential size. 7
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Simultaneous measurements of the population spike and population EPSP revealed 
that the depression of spike size was greater than the decrease of EPSP size during the 
application of ATP, leading to a dissociation of the E-S relationship (i.e. E-S 
depression). However, the subsequent long-lasting potentiation following perfusion 
reached a similar magnitude for both components compared with control values (Fig. 
4.3) restoring the E-S coupling. An alternative description of this result, however, 
would be that, compared with the sizes of the population spike and population EPSP 
during the application of ATP, the subsequent potentiation of population spike size 
amplitude was greater than that of the population EPSP.
When a higher concentration of 40 pM ATP was used, the inhibitory response 
was much larger, almost totally inhibiting the response in most slices, but this was not 
followed by any long-lasting potentiation of responses (Fig. 4.4).
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Figure 4.1. Raw data of a population spike recorded from the stratum pyramidale of a 
rat hippocampal slice. Trace (a) shows the control evoked response (measured at an 
amplitude 70% of maximum control size). 30 min following washout of a 10 min 
application of ATP the response is potentiated to 138% of control size (b).
[Initial control size = 2.2 mV; potentiated spike size = 3.04 mV]
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Figure 4.2. The effect of ATP 2.5 |iM on population spike amplitude. During 
perfusion no effect on population spike amplitude was seen. However, 30 min 
following perfusion of ATP 2.5 pM responses were potentiated to 127.813.7% of 
control values (n=3, p<0.05).
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Figure 4,3. The effect of 10 min perfusion of ATP 10 pM on population spike (pop 
spike) amplitude (n=5) and EPSP slope (n=3). During perâision, the population spike 
amplitude was reduced by a greater extent that the EPSP slope which caused a 
dissociation in the EPSP-spike relationship. Following perfusion of ATP, responses 
recovered to values greater than controls, resulting in long-term potentiation.
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Figure 4.4. The effect of ATP 40 pM on population spike amplitude. During 
perfusion of 40 pM ATP population spikes were almost completely inhibited. No 
long-term potentiation was observed following washout of ATP, in fact population 
spike amplitude remained inlhbited 30 min after ATP was removed from the system 
(n=3).
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The effect o f  bath temperature on responses to ATP perfusion 
Reducing the temperature in the recording chamber from 31 °C to 28 °C resulted in an
attenuation of the inhibition of population spike amplitude during application of ATP 
10 pM (Fig. 4.5). At 31 °C the population spike amplitude was reduced to 33.9 ±13.7 I
% of control values while at 28 it was reduced to 54.5 ± 12.3 % of control values. 7
At 28 C no long-term potentiation of population spike amplitude was observed 7
following washout of ATP. (
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Figure 4.5. The effect of lowering the temperature in the perfusion chamber on 
responses to ATP. No long term effects on population spike amplitude were observed 
following perfusion of 10 pM ATP at 28 °C. During perfusion, less inliibition was 
seen at 28 °C than at 31 °C, however this was not significant.
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The effect o f ATP analogues on evoked potentials.
The stable analogue of ATP, apmethyleneATP (apMeATP) at 10 pM caused a slight 
decrease in population spike size during perfusion but had no long-term effects on 
either population spike size or population EPSP size on washout (Fig. 4.6). Another 
analogue of ATP, j3ymethyleneATP (pyMeATP) at 10 pM, caused a significant 
depression of population spike amplitude during perfusion to 10.9 ± 0.2% of control 
(p<0.001), followed by a degree of excitation on washout (118.6 ± 10.2% at 5 min 
following washout (not significant). However, no long-lasting potentiation of 
response size was observed (Fig. 4.7). A 10 min application of 2MeSATP (10 pM,
11=3 ) or 10 pM UTP (n=3) (Fig 4.8) also caused no significant long-term effects on 
evoked potentials.
When P2 and PI receptors were activated at the same time using 10 pM a[3MeATP
and 50 pM or 10 pM adenosine, a significant reduction of population spike amplitude
was observed during perfusion (to 12.9 ± 1.7% of control with 10 pM adenosine and
.3.6 ± 0.9% of control with 50 pM adenosine; p<0.001 in both cases). On washout, 
both combinations resulted in an increase in response size, which was not 
significantly different from controls (Fig 4.9, 4.10). When 10 pM 2MeSATP and 10
AT?pM adenosine was perfused, a significant inliibition of population spike amplitude 
was observed. On washout of drugs the responses returned to control levels. (Figure 
4.11)
81
A T P  ind u ced  L T P
1 20
1 0 0
cn 6 0
4 0
20
a l p h a  -  b e t a  m A TP  l OuM
T A xTvj  yZv o
w
: §
10
@ p o p  s p i k e  
V EPSP
20 3 0
t i m e  ( m i
40  
n  = 3
5 0
Figure 4.6. The effect of the stable analogue of ATP, a,p-methylene ATP (ap- 
MeATP), on population spike amplitude and EPSP slope. Perfusion of 10 pM ap- 
MeATP caused a decrease in PS amplitude to 81.6 ± 10.2 % of control (not 
significant) which recovered when it was washed out.
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Figure 4.7. The analogue of ATP, p,ymethyleneATP (p,yMeATP) 10 pM, caused 
a significant reduction of population spike size during perfusion (to 10.9 ± 0.2% of 
control, p<0.001). No long-term effects were observed.
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Figure 4.8. The effect of UTP 10|.lM on population spike amplitude.
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Figure 4.9. The effect of activating PI and P2 receptors using apMeATP 10 pM 
and adenosine 10 pM respectively. During perfusion of the two drugs, the population 
spike amplitude was significantly inliibited -presumably by adenosine acting on A| 
receptors. No significant long-term effects on population spike amplitude was 
observed.
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Figure 4.10. The effect of activating PI and P2 receptors using a(3MeATP 10 pM 
and adenosine 50 pM respectively. During perfusion, a significant inhibition of 
population spike amplitude 3vas observed. Following washout, an increase in 
amplitude was observed, however this was not significant 30 min aher perfusion of 
drugs.
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Figure 4.11. The effect of activating adenosine receptors and P2 receptors 
separately on population spike amplitude. The non-hydrolysable analogue of ATP, 
MeSATP and adenosine were used to activate P2 and adenosine receptors 
respectively. When the drugs were washed out of the system population spike 
amplitude returned to control values.
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The effect o f adenosine antagonists on responses to ATP
A concentration of 10 pM ATP was selected with which to examine in more detail the 
pharmacology of the potentiation seen following application of ATP to slices. The 
adenosine PI receptor blocker 8 -phenyltheophylline (8 PT) (10 pM) and the selective 
adenosine Ai receptor antagonist 8 -cyclopentyl-1,3-dipropylxanthine (DPCPX) 
(lOOiiM) both abolished the inliibitory component of the response to ATP. Similarly, 
the long-term effects of ATP perfusion were abolished upon antagonism of PI 
receptors (Figs. 4.12 , 4.13).
In the presence of the non-xanthine adenosine A.2^ receptor antagonist, ZM 241385 
(50 iiM), perfusion of ATP 10 pM caused no inliibition of population spike amplitude 
or EPSP slope. In fact, potentiation of responses started during ATP perfusion. The 
responses remained potentiated 30 min following washout of ATP, with population 
spike amplitude reaching 124.5+7.0% (p < 0.01) of control value and EPSP slope 
reaching 125.7±5.4% (p < 0.01) of control value 30 min following washout (figure 
4.14). In contrast, 8-(3-chlorostyryl)caffeine (CSC) another (xanthine) AzA receptor 
antagonist, had no significant effect on the inhibition seen during ATP perfusion in 
the slices. However, no resulting LTP was observed on washout (figure 4.15).
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Figure 4.12. The effect of blocking adenosine Ai receptors with 100 nM 8 - 
cyclopentyl-1,3-dipropylxanthine (DPCPX) on responses to ATP 10 pM perfusion.
Both the inliibition during perfusion of ATP (p < 0.01), and the potentiation of 
responses (p < 0.05) following perfusion were significantly inliibited in the presence 
of DPCPX.
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Figure 4.13. The effect of blocking adenosine receptors with 10 pM 8 - 
phenyltheophylline (8 -PT) on the actions of ATP 10 pM on population spike 
amplitude and EPSP slope. The inhibition during perfusion of ATP was significantly 
attenuated (p < 0.001) in the presence of 8 -PT, as was the potentiation of responses 
following perfusion (p < 0.05).
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Figure 4.14. The effect of the Aia antagonist 4-(2-[7-amino-2-{2- 
furyl}{l,2,4,}triazolo{2,3-a}{l,3,5}triazin-5-yl-amino]ethyl)phenol (ZM 241385) on 
ATP-indiiced responses.
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Figure 4.15. The effect of adenosine A%A receptor antagonist CSC on responses to 
ATP.
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The effect o f adenosine deaminase on responses to ATP perfusion.
Superfusion with adenosine deaminase at a concentration of 0.2U.mf' reduced the 
size of the inhibitory component of the response to ATP. Following removal of the 
nucleotide, the potentials increased in size to a value greater than the control level to a 
maximum of 117.1 ± 4.1% (p < 0.01), but this was not maintained, declining to 
control values within approximately 20 min. (Fig. 4.16).
The effect o f suramin on responses to ATP.
Suramin (50 pM) was perfused for 10 min before the addition of ATP to the slices 
and left in contact with the slices during the washout phase. In the presence of 
suramin, ATP depressed responses to 36.4 ± 10.8% of control after 10 min (not 
significantly different from ATP alone). However, the development of LTP during 
ATP washout was completely prevented (values after 30 min washout 99.1 ± 7.9%) 
(Fig. 4.17).
In order to determine whether suramin was affecting the induction or 
maintenance phases of long-term potentiation, this experiment was repeated with 
suramin being applied to slices immediately and 10 min after the application of ATP. 
Application of suramin immediately after ATP perfusion delayed the return of 
potential size to control values, but no long-term potentiation of the population spike 
was observed (figure 4.18). However if suramin was applied 10 min following the 
induction of LTP (i.e. 10 min following the washout of ATP), a depression of 
responses was observed which on washout returned to potentiated values (figure 
4.19).
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Figure 4.16. The effect of removing adenosine from the system using adenosine 
deaminase 0.2 U/ml on responses to ATP. No inhibition of population spike 
amplitude was observed during perfusion of 10 pM ATP. Following perfusion of 
ATP responses were potentiated for approximately 15 min. However, 30 min 
following washout of ATP responses were no longer potentiated and were not 
significantly different from control values.
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Figure 4.17. The effect of the P2 antagonist suramin 50 |_iM on responses to ATP 10 
pM perfusion. Perfusion of ATP caused an inliibition of population spike amplitude 
which recovered to control values when ATP was removed from the system. No 
potentiation of responses was seen in the presence of suramin.
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I Figure 4.18. Perfusion of suramin 50 pM for 10 min immediately following ATP
perfusion prevents the development of LTP. PS amplitude 30 min after washout was 
93.1 ±2.33 % (not significantly different from control).
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Figure 4.19. Perfusion of suramin 50 pM 10 min after ATP perfusion delayed the 
development of LTP. However, 30 min following washout PS amplitude was 
potentiated to 133.8 ± 6.8% of control (p < 0.05).
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The effect o f an N-methyl-D-aspartate (NMDA) antagonist on responses to ATP. 
Inclusion of the NMDA antagonist 2-amino-5-phosphonopentanoic acid (AP5) (50 
pM) for 10 min before and during the application of ATP did not change the 
inhibitory effect of ATP but prevented completely the development of LTP (Fig 4.20)
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Figure 4.20. The effect of the NMDA antagonist, 2-amino-5-phosphonopentanoic 
acid (AP-5) 50 pM on responses to ATP 10 pM. When AP-5 was perfused for 10 min 
before and during ATP perfusion, no effect on the inhibition caused by ATP was 
observed, however following perfusion of ATP responses returned to control values 
with no potentiation of responses.
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size during perfusion which recovered to potentiated levels following washout. No 
further potentiation of responses was observed following ATP perfusion (figure 4.21). 
Interestingly, the profile of inliibition seen during ATP perfusion when the slices were 
potentiated electrically differs from that seen in unpotentiated slices, in that the time 
taken to reach maximum depression is longer in potentiated slices.
In order to ensure that the LTP seen after high frequency stimulation was saturated, 
three consecutive bursts of 100 Hz for 1 second were delivered to the slices until no 
further potentiation of responses was observed. Slices were potentiated to 168.9 ± 
12.2% of control value following the third burst. Application of ATP in this case 
again did not result in any further potentiation of responses (value following 30min 
washout, 158.8 ± 12.9%, figure 4.22).
When long-term potentiation was first induced using ATP, a burst of high frequency 
stimulation 30 min following washout resulted in a further potentiation of responses 
(figure 4.23) to an extent not significantly different than that seen when HFS was used 
first (figure 4.21).
Occlusion o f electrical- and ATP-induced long-term potentiation.
A set of experiments were performed in order to assess the relationship between the
mechanisms of electrically-induced long-term potentiation and that produced by ATP.
When LTP was induced electrically by stimulating the slices at high frequency (100
.Hz for 1 second), an application of ATP for 10 min resulted in a decrease of response
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Figure 4.21, The effect of electrically inducing LTP before perfusion of 10 juM ATP. 
Application of ATP 30 min following induction of LTP using high-frequency 
stimulation resulted in a depression of evoked responses similar in magnitude to that 
seen in unpotentiated slices. On washout, population spike amplitude returned to 
potentiated levels with no further potentiation of responses.
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Figure 4.22. The effect of perfusion of ATP following saturation of LTP using 
consecutive bursts of high-frequency stimulation.
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Figure 4.23. The effect of high-frequency stimulation on responses that have been 
potentiated following ATP application. Perfusion of 10 pM ATP resulted in a 
potentiation of population spike amplitude to 144.9 ± 27.5% of control levels 
following 30min washout. A high-frequency burst of stimulation further potentiated 
the responses to 194.3 ± 32.03% of control levels.
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Repeated applications o f ATP.
of electrically induced LTP, i.e. by repeated applications if the LTP-inducing stimulus. 
However, whereas repeated bursts of 100 Hz stimulation for 1 s resulted in a robust, 
saturable form of LTP (fig. 4.21), repeated applications of 10 pM ATP gave varied 
results. Figures 4.24 -  4.26 give examples of 3 experiments in which repeated 
applications of ATP were perfused over slice preparations.
In figure 4.24, the first application of ATP resulted in an approximately 50% 
potentiation of population spike amplitude. However, after a second application of 
ATP, responses were not potentiated further. In fact, the response fluctuates below 
control levels. A burst of HFS resulted in a very large potentiation of response size to 
approximately 200% of control level.
In the experiment shown in figure 4.25, responses remained potentiated after a second 
application of ATP. However, a third application resulted in responses taking longer 
to recover to control values and no potentiation. Again, when a burst of HFS was 
given, a potentiation of responses, greater than that following the two applications of 
ATP, was observed.
In figure 4.26, application of ATP resulted in a very large potentiation of spike 
amplitude, although the magnitude of potentiation was not consistent. Following 
another two applications of ATP, the responses were still potentiated to approximately 
the same level. Again, a burst of HFS further potentiated the responses.
Attempts were made to saturate ATP-induced LTP in the same mamier as saturation
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Figure 4.24. The effect of repeated applications of ATP on a slice preparation. 
Following the second application of ATP, the initial potentiation of population spike 
amplitude disappeared. A burst of HFS still produced LTP of responses.
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Figure 4.25. The effect of repeated applications of ATP on a slice preparation. 
Population spike amplitude remained potentiated following two successive 
applications of ATP. A third application removed the potentiation. A burst of HFS 
resulted in a higher degree of potentiation than following ATP perfusion.
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Figure 4.26. The effect of repeated applications of ATP on a slice preparation. 
Following three successive applications of ATP, population spike amplitude was 
greatly potentiated. A subsequent burst of HFS further potentiated the responses.
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Diadenosine polyphosphates.
PI, P6-diadenosine hexaphosphate (ApôA) was applied at concentrations of 1 and 5 
pM. At 5 pM, population spike amplitude was reduced to 30.7 ± 10.2 % of control 
values with a smaller decrease in the size of the population EPSP (62.6 ± 3.15% of 
control) during perfusion of ApôA (fîgm*e 4.27). A concentration of 1 pM was used in 
two slices. The results for an individual slice are shown in figure 4.28. In this case 
the population spike amplitude and EPSP slope was reduced by the same extent. In 
neither case was there evidence for a subsequent increase of potential amplitude and 
long-term potentiation (figure 4.27, figure 4.28).
Perfusion of 10 pM PI, P5-diadenosine pentaphosphate (ApgA) decreased population 
spike amplitude to 43,5 ± 10.9% (p<0.001) and EPSP slope to 81.8 ± 0.9% (p<0.001) 
of control. On washout, the responses increased with population spike reaching a 
maximum of 118.2 ± 5.8 % of control 15 min following washout (p<0.05) and EPSP 
slope reaching a maximum of 127.4 ± 19.5 % of control at 18 min. However, 30 min 
following washout the responses were not significantly different from controls (figure 
4.29).
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Figure 4.27. The effect of Ap^A 5pM on population spike amplitude and EPSP 
slope.
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Figure 4.28. The effect of ApgA IpM on population spike amplitude and EPSP 
slope in an individual slice.
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III. Discussion.
The results support the view that ATP can induce a form of LTP in the hippocampal 
slice. The reason why LTP was only observed in slices with smaller starting 
potentials is not entirely clear, but may relate to the degree of enzymic activity 
available to metabolise the nucleotide to AMP and adenosine. Small starting spikes 
may be the result of the slices being in less good condition. Alternatively, the size of 
the spike may be a function of the number of available axons for activation by the 
stimulating electrode. This in turn will vary with the precise angle of cut of the slice 
and its position along the rostrocaudal axis of the hippocampus.
The inhibitory component of the response to ATP was blocked by the PI receptor 
antagonist 8-phenyItheophylline (8PT) and the adenosine Ai receptor selective 
compound DPCPX. This may mean that ATP is acting directly on the PI receptor to 
cause the inhibitoiy effect, or more likely that it is being hydrolysed to adenosine 
since adenosine deaminase also prevented the inhibitory phase during ATP perfusion. 
This would be consistent with other investigators who showed that inhibition by 
extracellular ATP of hippocampal synaptic transmission required the localised 
extracellular catabolism by ecto-nucleotidases and channeling of the generated 
adenosine to inhibitory adenosine Ai receptors (Cunha et al, 1998). Blocking PI 
receptors with the antagonists also inhibited the induction of LTP following ATP 
perfusion, and adenosine deaminase prevented its maintenance, resulting in only a 
short term potentiation of responses. In addition the stable analogues of ATP, a(3“ 
methyleneATP and 2MeSATP had no long term effects on the slices. Taken together,
'"L
f
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these results suggest that the depressant action of ATP is due to its conversion to 
adenosine, but that the subsequent enhancement of potential size requires the 
activation of both PI and P2 receptors. Activating both types of receptor using 
adenosine and 2MeSATP did not result in a long-term potentiation of responses. This 
is probably due to the fact that not all P2 receptor subtypes are activated by 
2MeSATP.
T
‘L
As previously mentioned, the lack of selective P2 receptor blocking agents means that 
it is difficult to establish the exact role of P2 receptors in any biological response and 
the specific subtype involved. Nevertheless it is likely that the ability of suramin to 
block the induction of long-term potentiation by ATP represents blockade of a P2 
receptor. The use of suramin, however, requires careful analysis as it has been shown 
that this compound has other effects that may complicate the picture. For example 
suramin has been shown to inliibit ecto-nucleotidases (Beukers et a l, 1995; Ziganshin 
et a l, 1995; Bultmami et a l, 1996; Ziganshin et a l, 1996) and even enliance the
:effects of ATP in some systems (Bailey and Hourani, 1995). Further, suramin has 
been shown to inhibit glutamate receptor channels in hippocampal neurones 
(Nakazawa et a l, 1995; Peoples and Le, 1998). This should not have been the case in 
this study as the concentration of suramin used (50 pM), was lower than that seen to 
inhibit NMDA and non-NMDA type glutamate receptor channels and previous studies 
have confirmed that this is the case (Ross et a l, 1998). Interestingly, Wieraszko 
(1995) has demonstrated a suramin induced LTP in mouse hippocampal slices at 
concentrations of less than 30 pM and suggested that it may exert its action via a 
subpopulation of mouse P2 receptors or by decreasing the efficiency of inhibitory 
synapses.
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The nature of the P2 receptor involved cannot be determined from this study. 
Localisation of ATP receptors by ligand binding teclmiques (Bo and Burnstock, 1994; 
Balcar ei a i, 1995) and in situ hybridisation (Kidd et a i, 1995; Collo et al., 1996) 
show a broad distribution of P2X receptors in the hippocampus. P2 X4 and P2Xo ATP 
receptors are abundant in CA1-CA3 hippocampal pyramidal cells from adult rats 
(Collo et a i, 1996; Le et a l, 1998a), whereas in young animals P2Xi and several 
isoforms of P2 X2 are also present (Kidd et a l, 1995; Simon et al, 1997, Kanjhan et 
a l, 1999). P2X6 subunits do not form functional homomeric receptors. Plomomeric 
assemblies of P2 X4 subunits respond poorly to apmethyleneATP and are relatively 
insensitive to suramin. Combinations of P2 X4 and P2X^ subunits, however have been 
shown recently to be sensitive to the agonist effects of apmethyleneATP and blockade 
by suramin (Le et a l, 1998). The profile of the putative P2 receptor activated by ATP 
in this study is not consistent with any of these, and may indicate the involvement of a 
different heteromeric subunit combination.
The blockade of ATP-induced LTP by AP5 suggests similarities in the process of 
induction with LTP induced by electrical stimulation, since the latter is at least partly 
dependent upon the activation of NMDA receptors and can therefore be prevented by 
2AP5 (Davies et a l, 1981). A necessary trigger for electrically induced LTP is the 
influx of calcium into the dendritic spine tlu'ough NMDA receptors which have been 
relieved of their Mg’*" block following depolarisation (Collingridge et a l, 1988). In 
contrast, the current through ATP receptor channels is not blocked by Mg”^ and thus 
calcium dependent phenomena such as LTP could occur without prior depolarisation. 
In addition to this postsynaptic effect, the calcium permeability of ATP receptors
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could result in presynaptic enhancement of transmitter release. ATP has been shown 
to elicit the release of glutamate in the hippocampus (Inoue et a l, 1992) and such an 
effect could account for the production of LTP.
The involvement of a common mechanism of ATP- and electrically-induced LTP is 
supported by the finding that the saturation of electrically induced LTP prevents the 
establishiuent of ATP-induced LTP. This in turn raises the question of whether 
electrieally-induced LTP might involve the activation of ATP receptors. The fact that 
ATP is preferentially released upon high frequency stimulation (Cunlia et a l , î 996a) 
also supports this idea. One difference that does occur between electrically- and ATP- 
induced LTP is that no EPSP-spike dissociation occurs upon ATP-induced LTP. 
However, this was only measured at one stimulation intensity (i.e. that giving a 
response 70% of maximum control). Several groups have reported a potentiation of 
the EPSP-spike relationship following electrically induced LTP (see for example 
Bernard and Wheal, 1995a,b) and the phenomenon has become an established feature 
of this form of LTP. A reason for this difference in ATP- versus electrically induced 
LTP may be that the LTP induced by ATP perfusion was not saturated. Whereas 
electrically induced LTP produced a robust LTP which could be saturated by repeated 
high frequency bursts until no further increase in response size was observed, it 
proved difficult to do the same using repeated applications of ATP. It may be the case 
that the LTP induced by ATP forms a component of that induced by high frequency 
stimulation i.e. ATP induces the synaptic component of LTP, reflected in the 
potentiation of the EPSP, resulting in an enhanced excitatory input to the neuronal 
pool and concomitantly increasing the number of synchronously dischai'ging cells to 
produce a larger population spike, while high frequency stimulation leads to the
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second component - EPSP-spike potentiation. It has been suggested that different 
mechanisms may underlie the two components of LTP. High frequency stimulation 
may induce potentiation of one component but not the other (Bliss and Lomo, 1973; 
Wilson et al., 1981; Abraham et a l, 1985; Taube and Schwartzlcroin, 1988). Also, a 
brief elevation in extracellular calcium, which mimics tetanus-induced LTP (Turner et 
al, 1982), does not produce EPSP-spike potentiation (Reyman et a l, 1986; Bliss et a l, 
1987).
An alternative analysis of the lack of EPSP-spike potentiation 30 min following ATP 
application, however, would be that, compared with the sizes of the population spike 
and population EPSP during the application of ATP (i.e. the population spike was 
inhibited to a greater extent that the EPSP), the subsequent potentiation of population 
spike size amplitude was greater than that of the population EPSP, resulting in a 
potentiation of the EPSP-spike relationship albeit not from control values but from 
values following 10 min perfusion of ATP.
It has been suggested that ATP-induced LTP is due to ecto-protein kinase enzymes 
using ATP as a substrate, on the basis that, as confirmed here, aj3MeATP does not 
mimic the LTP induced by ATP (Wieraszko and Erlich, 1994) and that an inhibitor of 
ecto-protein kinase, K-252b, which competes with ATP for the catalytie site of the 
kinase (Kase et a l, 1987), prevents the establishment of LTP by ATP (Fujii et a l, 
1995). This kinase inliibitor has also been shown to block electrically induced LTP 
(Reymami et a l, 1990; Fujii et a l, 1995). Interestingly, the involvement of ecto- 
protein kinase in electrically induced LTP has been proposed by Chen et a l (1996) 
with the demonstration that LTP can be prevented by a monoclonal antibody to the
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catalytic domain of protein kinase C. In other studies using “knockout” animals for 
various protein kinases electrically-induced LTP was more difficult to elicit but was 
not absent (Abeliovieh et a l, 1993; Grant and Silva, 1994) suggesting compensatory 
or redundant mechanisms in the induction of LTP. These studies support the idea that 
ATP may contribute to electrically-induced LTP.
Dinucleotides
The adenine dinucleotides have been thought to act on ATP (P2) receptors since the 
original discovery of their actions on smooth muscle (Stone, 1981a). In the present 
study the most potent of these, Ap^A, produced only inlribition of the slices, whereas 
ApsA caused an inhibition, followed by a rebound excitation of responses following 
washout which did not develop into a long-lasting potentiation. The lack of long-term
effects following perfusion of diadenosine polyphosphates suggests that the receptors ifI
responsible for the ATP-induced LTP are not sensitive to dinucleotides.
As previously mentioned, dinucleotides have been suggested to act on P2 
receptors, either as an uncleaved molecule, or due to enzymatic breakdown to ATP &
ADP. Alternatively, evidence exists showing that the dinucleotides may act on a 
specific dinucleotide receptor which allows Ca^’*' influx in the synaptic terminal. In 
this scenario, the dinucleotides may act as positive modulators of synaptic 
transmission. Ap$A has been shown to elevate intrasynaptosomal calcium (Pintor et 
a l, 1995), an effect which may underlie the inerease in response seen immediately 
following perfusion of ApsA in this study.
In summary, this study has shown for the first time, that in the rat hippocampus slice 
preparation, a form of long-term potentiation that can be induced by superfusion of
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ATP. The phenomenon shows several similarities to electrically-induced LTP, and 
may involve the simultaneous activation of PI and P2-purinoceptors. Another 
important finding of this study has been the novel action of ZM 241385 on the 
adenosine Ai receptor-mediated inhibition of evoked potentials during ATP perfusion, 
an effect which warrants further investigation.
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CHAPTER 5.
STUDIES USING 5'ADENYLIC ACID DEAMINASE
(AMPASE).
I. Introduction.
As a consequence of the observation by Ross (1997) that, following a 10 min 
perfusion of adenylic acid deaminase (AMPase), a long lasting depression of 
responses was observed, it was decided to further investigate and characterise the 
effects of AMPase on hippocampal slices.
During the course of investigations it became apparent that the aminohydrolyase 
activity of the enzyme preparation was not responsible for the long-term 
depression (LTD) of evoked responses in the hippocampus. Further, the 
Icnowledge that extraction of many enzymes on an industrial scale can lead to a 
number of impurities being present, prompted the decision to purify the enzyme 
prepai'ation in order to determine the active component involved.
The purification process led to the discovery that the factor causing long-term 
depression of evoked potentials in rat hippocampal slices was not in fact AMPase 
but an unloiown protein.
The task in hand then became to identify the protein present in the crude enzyme 
preparation that caused the long-lasting depression of evoked potentials. This
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entailed the scaling up of the purification process and subsequent sequencing of 
the purified protein (see appendix 1 and 2).
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Perfusion o f AMPase.
An example of the inhibition of responses seen 30 min after washout of a 10 min 
application of AMPase (E.G. 3.5.4.6. from Aspergillus) is illustrated for a single 
slice in the raw traces in figure 5.1. Figure 5.2 shows the time eourse of such an 
effect on population spike amplitude and population EPSP slope in 5 slices. 
Following the start of perfusion of AMPase, there is an initial increase in the size 
of CAl orthodromic population spike amplitude whieh gives way to a decrease 
in potential size following removal of the enzyme. The inhibition of population 
spike amplitude and EPSP slope in the set of slices studied in figure 5.2 was 42.7 
± 13.4% (p< 0.01) and 59.3 ± 6.9% (P < 0.01) of initial control potential size 
respectively. The depression develops slowly, over a period of approximately 
10-20 min, but persists for as long as recordings were made (up to 90 min).
The long -lasting depression effect of AMPase did not appear to be the result of 
a toxic effect on the slices for 2 reasons. Firstly, the neurones remained capable 
of returning to control responses when stimulation amplitude was increased 
following depression (figure 5.3). Secondly, long-term potentiation could still be 
induced by a standard tetanus of 100 Etz for 1 second (figure 5.3).
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Figure 5.1 Raw traces from a single slice, (a) shows the population spike (PS) 
and population excitatory potential (EPSP) before the addition of AMPase to the 
perfusion medium. The traces in (b) show the same responses 30 min following 
perfusion of AMPase. In this slice, PS amplitude was reduced by 35%, whereas 
the EPSP slope was reduced by 19% 30 min following perfusion of 2 U/ml 
AMPase.
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Figure 5.2. The effect of a 10 min application of AMPase on population spike 
amplitude (filled circles) and population EPSP slope (open triangles). During 
perfusion, an initial increase of population spike amplitude was observed, which 
started to decline approximately 7 min after the start of perfusion and continued 
to decline before reaching a plateau approximately 15 min after washout. The 
response remained depressed 30 min following washout. The population EPSP 
slope decreased during perfusion of AMPase but recovered to a still depressed 
level following washout. Again the depression of population EPSP slope was 
observed 30 in following washout of AMPase.
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Figure 5.3. The perfusion of AMPase caused a long-term depression of 44.7 ± 
8.9% (p<0.01) of control values. Responses could be returned to control values 
by increasing the stimulation amplitude (bar below record). Depressed responses 
could also be potentiated following a burst of high frequency stimulation (100 Hz 
for 1 second; arrow).
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Effects o f AMPase on EPSP-spike coupling.
When simultaneous measurements were made of the CAl population EPSP and 
population spike, which primarily reflect transmitter release and postsynaptic 
excitability respectively, it was found that the population spike was depressed to 
a larger extent than the population EPSP (figure 5.4, 5.5a). The relationship 
between the two -  the EPSP-spike coupling -  showed a shift to the right (figure 
5.4c) indicating that the AMPase was reducing the ability of EPSPs to induce a 
postsynaptic spike and implying that the enzyme was acting postsynaptically to 
modify spike thi'eshold. Data from 5 slices show that the ratio PS/EPSP was 
significantly changed from control values 30 min after washout of AMPase 
confirming that population spike amplitude was decreased by a greater extent 
compared with EPSP slope (figure 5.5b).
The effect o f  AMPase from a different source.
The effect of AMPase extracted from rabbit muscle was tested on slices in order 
to determine if it was the Aspergillus form of the enzyme specifically that caused 
the long-term depression of evoked potentials. A 10 min perfusion of AMPase 
from rabbit muscle caused a biphasic response- initially increasing potentials to 
115.0 ± 5.4% of control (p<0.05) which then started to decline after 
approximately 5 min (to 75.4 ± 17.9%, n.s.). On washout, the responses returned 
to values greater than control (117.0 ± 5.3 %; p<0.01) but then decreased and 
remained at control levels persistently. No long-term depression was thus 
observed with the rabbit form of AMPase (figure 5.6). Control for AMPase from 
rabbit was the vehicle it was prepared in i.e. 66% glycerol solution containing 1 
mM mercaptoethanol and 0.33 mM KCl, pH 7.0.
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Figure 5.4. Input-output curves for a typical slice (and corresponding E-S curve) 
showing the effects on responses before (filled circles), and 30 min following 
(open triangles) AMPase perfusion. It can be seen that both population spike 
amplitude and population EPSP slope were depressed 30 min following washout 
of AMPase. Population spike amplitude (a) was depressed to a greater extent 
than population EPSP slope (b) resulting in a right-shift in the E-S curve (c).
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Figure 5.5. Pooled data from 5 slices, showing the decrease in population spike 
amplitude and population EPSP slope 30 min following washout of a 10 min 
perfusion of AMPase. Population spike amplitude was decreased to 42.1 ± 7.1% 
of control compared with 61.8 ± 5.3 % of population EPSP slope (a). When the 
ratio PS/EPSP was calculated before and 30 min following AMPase perfusion, it 
was observed that for the same population EPSP slope, a smaller population 
spike was seen, revealing a depression in the EPSP-spike relationship.
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Figure 5.6. The effect of AMPase extracted from rabbit muscle on population 
spike amplitude. 10 min perfusion of lU/ml AMPase caused an initial increase 
in population spike amplitude which started to decline during perfusion. On 
washout, there was a rebound excitation of population spike amplitude which 
returned to control values approximately 10 min following washout. No long­
term effects on response size was observed.
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The effect o f urease and 5 'nucleotidase on evoked potentials.
AMPase forms a member of the aminohydrolase superfamily related to urease. 
(Holm and Sander, 1997). It was decided therefore to examine the effects of 
another aminohydrolase, namely urease, on evoked potentials. Urease at a 
concentration of I and 2 U/ml had no significant effects on slices (figure 5.7, 
5.8). 4 U/ml urease caused a depression of population spike amplitude during 
perfusion to 59.3 ±13.9% of control (p<0.05), but responses returned to control 
values on washout (figure 5.9).
Another enzyme involved in purine metabolism is 5’ nucleotidase. This enzyme 
had an inliibitory action on evoked potentials during perfusion but had no long­
term effects on population spike amplitude 30 min after washout (figure 5.10).
Perfusion o f Aspergillus extract.
A culture of Aspergillus nidulans was grown and homogenised. The homogenate 
was suspended in aCSF and perfused over the slices. Figure 5.11 shows that 
during perfusion of the crude Aspergillus homogenate, an immediate depression 
of population spike to 35.2 ±1.3% (p<0.01) was observed. The responses were 
still depressed 30 min following washout of the homogenate to 74.5 ± 4.2% of 
control (p<0.05).
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Figure 5.7. The effect of urease lU/ml on population spike amplitude. No 
significant effects on response size were observed. Vi
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Figure 5.8. The effect of urease 2U/ml on population spike amplitude.
Following washout a small potentiation of response size was observed, however,
no significant long-term effects on population spike amplitude were observed.
■ i:,
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Figure 5.9. The effect of urease 4U/iiil on population spike amplitude. During 
perfusion, population spike amplitude was significantly depressed. On washout, 
responses returned to control values.
13!
S tudies using  5 ' ad en y lic  acid d eam in ase
12 0
00
BO
60
4 0
0.2U/ini 5 ’-nucleotidase
20
504020
Effect of 5’nucleotidase 0.2U/ml on PS amplitude
Stud ies u s in a  5 ’ ad en y lic  ac id  d eam in ase
1 2 0
2 0  a s p e r g i l l u s  e x t r a c t
O
O 1 0  2 0  3 0
t i m e  ( m i n )
Figure 5.11. Perfusion of Aspergillus extract caused a significant decrease in
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population spike amplitude, which remained depressed 30 min following 
washout.
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The effect o f an inhibitor o f  AMPase.
The allosteric inhibitor of AMPase, 2,3-diphosphogiyceric acid (2,3-DPG) was
4
:
The effect o f AMPase on potentiated slices.
Slices were potentiated using high frequency stimulation of 100 PIz for 1 second.
Long-term potentiation was observed for 30 min before application of AMPase, 
at which time the population spike amplitude was potentiated to 147.4 ± 10.5% 
of control (p<0.01). Perfusion of AMPase caused a non-significant decrease of 
responses to 123.6 ± 25.0%, which recovered during washout before decreasing : J
to unpotentiated levels (83.9 ± 8.6%, p<0.01 compared with potentiated values, 
not significantly different from control values), thus causing a long-term |
depression of the potent!atiated response (figure 5.12).
:
■t:
-I
used in an effort to block the actions of AMPase on evoked potentials. fI
2,3-DPG alone caused a significant depression (to 53.4 ± 9.7% of control, 
p<0.01) of population spike amplitude during perfusion which recovered to 
control values on washout (figure 5.13). When 2,3-DPG was perfused with 
AMPase no effects on either the initial increase of responses or the subsequent 
long-term depression following was observed. In the presence of 2,3-DPG,
AMPase still depressed the population spike amplitude to 31.9 ± 5.0% of control
(p<0.001) which is not significantly different from AMPase alone. f1)
iFigure 5.14 shows that AMPase does in fact inhibit the effects of AMP on 
evoked potentials. However when the allosteric inliibitor was used to block this 
inhibition the resulting long-term depression of responses was still observed.
:■!I
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Figure 5.12. The effect of AMPase on potentiated responses. When slices were 
stimulated using high frequency stimulation (HFS, 100 Hz for 1 second), long­
term potentiation (LTP) of responses was observed. Perfusion of AMPase 
0.2U/ml 30 min following the induction of LTP resulted in a depression of 
responses.
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Figure 5.13. The effect of the allosteric inhibitor of AMPase, 2,3- 
diphosphoglyceric acid (2,3-DPG) on responses to AMPase. 2,3-DPG by itself 
caused a significant depression of population spike amplitude, however when in 
combination with AMPase, 2,3-DPG had no effects on either the initial 
potentiation of responses during perfusion, or the resulting depression seen on 
washout of AMPase.
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Figure 5,14. The effect of AMPase on responses to AMP and subsequent 
perfusion of the AMPase inliibitor 2,3-DPG.
AMPase effectively inhibited the effects of AMP 50 pM, however, 2,3-DPG did 
not lead to a return of the AMP-mediated inhibition of responses, nor did it 
prevent the long-term depression of responses following AMPase perfusion.
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The effect o f trypsin inhibitor on responses to AMPase.
Trypsin may be present in significant quantities in some enzyme preparations.
To determine whether trypsin present in our AMPase preparation was I;
responsible for the long-term depression of responses we perfused trypsin |
inhibitor along with AMPase.
3'.'t!
I
Figure 5.15 shows that when trypsin inhibitor was perfused alone, a significant #■ft 
'1(p<0.05) depression of population spike amplitude was observed. When trypsin 
inhibitor was co-perfused with AMPase, no attenuation of the initial increase of 
responses, or the subsequent depression on washout was observed. The 
depression of responses when AMPase was co-perfused with trypsin inhibitor 
was 41.2 ± 8.9% of control values (p<0.001) which was not significantly 
different from the depression seen with AMPase alone.
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Figure 5.15. The effects of trypsin inhibitor on responses to AMPase.
Trypsin inliibitor caused a depression of population spike amplitude when 
perfused alone. However, when perfused in combination with AMPase, no 
effects on the initial potentiation of responses during AMPase perfusion, nor the 
subsequent long-term depression following washout were observed.
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Other efforts to inhibit the activity o f AMPase.
N-(2~aminoethyl)“5-chloro-l-napthalene sulphonarnide (A3) a non-selective 
protein kinase inhibitor was co-perfiised with AMPase, with no resulting 
modulation of the long-term depression observed (figure 5.16).
Indomethacin inhibits eyclo-oxygenase and hence metabolism of arachidonic 
acid. AMPase, in the presence of indomethacin (50 pM), continued to cause a 
resultant depression of population spike amplitude (figure 5.17).
-nitro-L-arginine methyl ester (L-NAME), a competitive inliibitor of nitric 
oxide synthase (NOS) alone caused no significant effects on evoked potentials, y
nor did it affect the magnitude of depression seen 30 min following AMPase 
perfusion. However, an increase in potential size was observed immediately 
following washout of the agents. This recovery was short-lived, and responses 
began to decrease approximately 10-15 min after the start of washout and 
remained depressed for 30 min (figure 5.18). The brain specific NOS inhibitor,
7-nitroindazoie (7-Nl), in contrast, had no effects on the time course of inhibition 
following AMPase perfusion (figure 5.19).
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Figure 5.16. The effect of N"(2-aminoethyl)~5-chlorO“l-napthalene 
sulphonarnide hydrochloride (A3 HCl) a general protein kinase inhibitor by itself 
(a) and co-perfused with AMPase (b).
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Figure 5.17. The effect of the cyclo-oxygenase inliibitor, indomethacin (50 pM) 
on responses to AMPase.
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Figure 5.18. The effect of the nitric oxide synthase inliibitor -nitro-L- 
arginine methyl ester (L-NAME) on responses to AMPase. L-NAME had no 
effects by itself (top) but inliibited the onset of long-term depression when co- 
perfused with AMPase.
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Figure 5.19. The effect of the specific brain nitric oxide synthase inhibitor, 1~ 
nitroindazole (7-NI) on responses to AMPase.
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Purification o f the active component present in AMPase preparation.
It became increasingly apparent that the factor present in the enzyme preparation 
responsible for the long-lasting depression of evoked potentials may not be 
AMPase.
As a first step to determine how pure the preparation was, a SDS-PAGE gel was 
run to separate the various components present. Figure 5.20 shows the results 
from such a gel. It is obvious from the number of bands present that the enzyme 
preparation was quite “dirty”.
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A sample of the crude enzyme extract was passed through a FPLC column and 
gel filtration column (see appendix 1) and fractions collected every 90 seconds. 
Simultaneous UV spectrum analysis at 280nm of the fractions to determine 
which contained protein was of limited worth, as the crude extract was brown in 
colour and hence absorbed UV light at the same wavelength.
In order to obtain a greater quantity of material to assay, a precipitation 
step using ammonium sulphate was used before clrromatography. Three 
concentration ranges were used to precipitate protein present in the crude 
preparation, i.e. 0-40%, 40-60%, and 60-80%. Of these, only protein that had 
precipitated in the 40-60% range caused long-term depression in the slice 
preparation (figure 5.21). The 40-60% sample was loaded onto the gel filtration 
column (Superose 12, Pharmacia) and fractions assayed on slices. Activity was 
seen in 3 of these fractions in increasing amounts (figures 5.22,5.23,5.24). The 
fractions were tested for the presence of AMPase using a biochemical assay (see 
appendix 1) and were also tested for depressant activity on slices. Interestingly,
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the fractions that contained the AMPase activity were different from those that 
produced LTD in hippocampal slices (see figs 5.25, 5.22, 5.23, 5.24). Figure 5.26 
shows a SDS-PAGE gel of the active fractions. It can be seen that a single 
protein band at approximately 90 kDa was present.
Identification o f the active protein.
The fraction containing the purified active protein was sequenced using Ed man 
degradation chemistry by Nick Morrice, MRC Protein Phosphorylation Unit, :t
Department of Biochemistry, Medical Sciences Institute, University of Dundee, I;
Iusing an Applied Biosystems Precise sequencer (see appendix 2). The sequence 
obtained was:
VTNWDQAYTQAKTALDK
I
This 17 amino acid sequence was entered into a number of protein databases on Ai
21st May 1999, including BLAST (http://www.blast.genome.ad.jp/), SwissProt A
(http://www.genome.ad.jp/dbget-bin/www_bflnd7swissprot-today), and FASTA
..x;
(http://www.fasta.genome.ad.jp/). No significant match with other known A
proteins was obtained. Further (internal) sequencing by tryptic digestion of the 
protein (Nick Morrice, University of Dundee) provided further information about A
the protein sequence (five extra sequences of varying lengths were obtained).
These internal sequences were also entered into the databases (June, 1999). The 
searches revealed that the sequences had a similarity to a (3-glucosidase molecule.
The purified protein fraction when assayed biochemically (H.G. Nimmo,
ji:
personal communication) showed some (3-glucosidase activity. Flowever, a
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preparation of [3-glucosidase, extracted from almonds when perfused over a slice 
in three different concentrations did not result in long-tenn depression of evoked 
responses (figure 5.27,5.28,5.29).
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Figure 5.20 5 and 15 pi of a sample of AMPase which was prepared for
chromatography (see appendix 1) was run on a 12.5% SDS-PAGE gel. A range 
of protein bands were apparent indicating that a variety of proteins were present 
in the crude sample.
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Figure 5.21. A protein in the crude AMPase extract which precipitated in 40- 
60% ammonium sulphate was responsible for long-term depression of population 
spike amplitude.
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Figure 5.22. The effect of fraction 14 eluted from a chromatography column on 
population spike amplitude.
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Figure 5.23. The effect of fraction 15 eluted from a chromatography column on 
population spike amplitude.
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Figure 5,24. The effect of fraction 16 eluted from a FPLC column on 
population spike amplitude. More depression of responses was observed than in 
the previous two fractions, suggesting most of the active component was present 
in this fraction.
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Figure 5.25. The AMPase activity of fractions 14, 15 and 16 when measured 
biochemically (see appendix 1) did not correlate with their depressant activity on 
population spike amplitude in the slice preparation.
1 5 2
Stud ies u s in e  5 ’ad en v iic  acid d eam inase
\
67
43
30
20.1
14 15 16
Figure 5.26 SDS-PAGE gel of fractions 14, 15 and 16 showing a single 
protein band present at approximately 90 IcDa.
153
S tu d ies usin g  5 'a d e n y lic  acid  d eam in ase
1 20
100  !  "  5
.  80
^  60 cu
o 40m
D 2 0
t i m e  ( m i n s )
Figure 5.27 The effect of a 10 min perfusion (bar) of 0.25U/ml p-glucosidase 
from almonds on population spike amplitude.
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Figure 5,28. The effect of a 10 min perfusion (bar) of lU/ml p-glucosidase 
from almonds on population spike amplitude.
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Figure 5.29 The effect of a 10 min perfusion (bar) of of 4U/ml (3-glucosidase 
from almonds on population spike amplitude.
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Inhibition o f  ^ -glucosidase.
Conduritol, an iiTeversible inliibitor of (3-glucosidase, was incubated for at least 
one hour with a 40-60% ammonium sulphate precipitated fraction of the crude 
enzyme extract.
A biochemical assay (see appendix 1) showed that p-glucosidase activity in the 
preparation was inliibited by conduritol (H.G. Nimmo, personal communication). 
However, when perfused over a slice, LTD of population spike amplitude still 
occcured (Figure 5.31) to an extent not significantly different from the 40-60% 
fraction alone (figure 5.30).
During perfusion of the fraction which had been incubated with conduritol, 
population spike amplitude was reduced to 72.4 ± 4.4% of control (p< 0.01). 
This was significantly different from the results seen when the 40-60% fraction 
was perfused alone (p<0.05).
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Figure 530, The effect of crude AMPase extract in which proteins were 
precipitated in 40-60% ammonium sulphate on population spike amplitude. 
Following 30 min washout of the extract population spike amplitude was 26.7 ± 
9.32 % of control (p < 0.01).
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Figure 5.31. The effect of crude AMPase extract in which proteins were 
precipitated in 40-60% ammonium sulphate and incubated for at least 1 hour with 
conduritol to inhibit p-glucosidase activity. Following 30 min washout of the 
preparation population spike amplitude was depressed to 21.8 ± 2.8 % of control
( p < 0 . 0 0 1 )
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Brain homogenates.
It was decided to examine whether an endogenous factor present in the brain was 
responsible for long-term depression of evoked potentials. The brain of a rat, 
pig, and guinea-pig were homogenised and precipitated in the same manner as 
the AMPase extract (i.e. using ammonium sulphate at concentration ranges 0- 
40%, 40-60% and 60-80%). The re-suspended precipitates were then perfused 
over a rat hippocampal slice.
:.p:
Neither rat or pig brain homogenates had any long-term effects on evoked 
potentials in any of the fractions tested. However, guinea-pig brain homogenate 
in which proteins had precipitated in the 40-60% ammonium sulphate range, 
caused a long lasting depression of population spike amplitude (figure 5.33,
5.34). Interestingly, this was the same range in which the crude AMPase extract 
caused LTD.
Figure 5.34 shows that the depression caused by guinea-pig homogenate 
precipitated in 40-60% ammonium sulphate - like that caused by AMPase 
perfusion (see fig 5.3) - could be reversed by increasing the stimulation 
amplitude. LTP could also be elicited in the slice using high frequency
I
stimulation ( 1 OOHz, 1 s).
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Figure 5.32. The effect of a perfusion of guinea-pig brain which had been 
homogenised and precipitated using 0-40% ammonium sulphate on population 
spike amplitude.
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Figure 5.33. The effect of a perfusion of guinea-pig brain which had been 
homogenised and precipitated using 40-60% ammonium sulphate on population 
spike amplitude.
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Figure 5.34. The depression caused by the 40-60% ammonium sulphate 
precipitation of guinea-pig brain could be reversed by increasing the stimulation 
amplitude (bar) or by high frequency stimulation (arrow).
163
S tu d ies u sin g  5 ’ad en y lic  ac id  d eam in ase
II
it 00 , .  » . '  » . . .  . . .  , . .  .  .  '  . .  .
tu
1 4 0
(D^ 120Q -U)
8 0
6 0
4 0
20
0
p p t e  6 0 —80%
164
0  1 0  2 0  3 0  4 0  5 0
t i m e  ( m i n s )  4
Figure 5.35 The effect of a perfusion of guinea-pig brain which had been 
homogenised and precipitated using 60-80% ammonium sulphate on population 
spike amplitude.
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The results show that perfusion of a preparation of AMPase (B.C. 3.5.4.6.) from 
Aspergillus species resulted in a long-lasting depression of evoked potentials in 
the hippocampal slice. Population spike amplitude was depressed to a greater 
extent than could be accounted for by the depression in EPSP slope, resulting in a 
depression of the EPSP-spike relationship. Initially it was postulated that the 
effect of AMPase was a result of a property of the AMPase molecule other than 
its AMP metabolism, due to, for example, the fact that inliibiting the enzyme 
with 2,3-DPG did not affect the long-term depression seen following perfusion. 
Similar observations were made using coformycin (T.W. Stone, unpublished 
observations), a recognised inhibitor of AMPase (Dancer et a i, 1997). This 
compound also prevents the inliibitory effect of AMPase on AMP responses, 
indicating successful inactivation of the enzyme, but did not prevent the long­
term depressant activity.
Contaminating ions present in the AMPase preparation were ruled out as 
mediators of the long-term effects by Ross (1997), who dialysed a solution of 
AMPase for four days. This treatment did not affect the enzymatic activity of 
AMPase or the LTD following perfuision. Further, boiling the enzyme 
preparation to denature the enzyme led to a removal of the long-term depression, 
suggesting that a protein (although not necessary the AMPase molecule) was 
responsible for the observed depression.
...
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The fact that responses could be restored by increasing stimulation amplitude and 
potentiated using high frequency stimulation indicates that the cells were not 
damaged in any way; the behaviour of the enzyme preparation is reminiscent of 
that of a pharmacological competitive antagonist, against which increasing the 
dose of agonist is able to overcome the blockade of receptor.
AMPase may have caused depotentiation of responses which had been 
potentiated using high frequency stimulation, a feature common to stimulating at 
low frequencies which has also been shown to cause LTD in hippocampal slices, 
suggesting that electrically- and AMPase- induced LTD may share common 
mechanisms. Unfortunately, as reported by many other investigators, LTD could 
not be established electrically using low-frequency stimulation (LFS) in the set of 
slices investigated (Barrionuveo et a l, 1980; Fujii et al., 1991; Bashir and
Collingridge, 1994; Errington et al., 1995; Wagner and Alger, 1996).
A
Interestingly, with the exception of Errington et a l , depotentiation of responses 
could be demonstrated in the same preparations by these groups.
The mechanism of LTD in the slices following AMPase did not seem to involve 
protein kinase, cyclo-oxygenase or nitric oxide. Ca^Vcalmodulin-dependent 
kinase 11 (CaMKII) (Stanton and Gage, 1996) and protein kinase A (Brandon et 
a l, 1995) have both been implicated in long-term depression. However, use of 
the non-specific protein kinase inliibitor A3 had no effect on the depression 
following perfusion of the AMPase preparation. Indomethacin is an ineversible 
inliibitor of cyclo-oxygenase, the enzyme responsible for the metabolism of 
arachidonic acid, which is formed following activation of phospholipase A]
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(PLA2). The final compounds derived from the metabolism of arachidonic acid 
aie termed the eicosanoids and include the prostaglandins, thromboxanes, 
leukotrienes and lipoxins. An inliibitor of PLA2 , broniophenacylbromide has 
been shown to reduce or inliibit LTD in the hippocampus (Fitzpatrick and 
Baudry, 1994; Normandin et a l, 1996). Indomethacin did not affect evoked 
potentials alone, nor did it affect the LTD seen following perfusion of the 
AMPase preparation. Normandin et al (1996), also demonstrated indomethacin 
did not reduce LTD in the hippocampus. They did, however, show that a 
lipoxygenase inliibitor partially blocked hippocampal LTD, implying that, 
although the PLA2/arachidonic acid pathway involving cyclo-oxygenase is not 
involved in the LTD seen following AMPase perfusion, other mediators derived 
de novo from phospholipids may be implicated.
Whereas the involvement of nitric oxide (NO) in cerebellar long-term 
depression is well accepted, its role in hippocampal LTD is a matter of 
controversy. Izunii and Zorumski (1993) have reported that the nitric oxide 
synthase (NOS) inhibitors L-N (G)-monomethylarginiiie and L- N(G)~ 
nitroarginine (L-NOArg) can block the induction of LTD following HFS in 
hippocampal slices. Similarly, Wu et a l (1997) showed that two novel NOS 
inlribitors, l-(2-trifluromethylphenyl)imidazole and 3-bromo-7-nitro-indazole 
also blocked the induction of LTD in the hippocampus, an effect which could be 
prevented by pretreatment with L-arginine, the substrate amino acid used by NOS 
for nitric oxide production. In contrast, other groups have seen no effect of NOS 
inhibitors on hippocampal LTD (Cummings el a l, 1994; Malen and Chapman, 
1997). In this study L-NAME delayed the onset of LTD in slices, suggesting that 
nitric oxide may play a role in the induction of this form of LTD.
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AMPase extracted from rabbit muscle did not have the same responses on slices, 
suggesting that a specific Aspergillus form of the enzyme was responsible for the 
LTD. This is reinforced by the fact that a homogenate of cultured Aspergillus 
nidulans also induced LTD of responses.
Separation of the AMPase preparation extracted form Aspergillus species on a 
polyacrylamide gel showed that a variety of proteins were present. The 
observation that the protein responsible for the long-term depression of evoked 
responses was not the same as that causing the metabolism of AMP when this 
(now obviously crude) enzyme preparation was separated by FPLC confirmed 
that it was not the AMPase molecule that was responsible for the observed 
depression.
Further purification and sequencing of the unknown (90 kDa) protein revealed 
that it was similar to a [3-gliicosidase. This enzyme participtes in the removal of 
glucose residues from oligosaccharides. A fungal form of the enzyme may act 
extracellularly to digest complex external saccharides to allow the growth of 
hyphae.
As previously mentioned the p-glucosidase was 90 kDa in size. It is known that 
some large molecules can be released by neurones. Acetylcholinesterase, for 
example, can be released into the extracellular space and recent work has begun 
to reveal effects of this enzyme on neuronal growth and development, including 
non-enzymatic functions of the molecule (Sternfield ei a l, 1998). Interestingly,
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guinea-pig brain homogenate, when precipitated using ammonium sulphate 
showed a long lasting depression of responses at the same cut (40-60%) as that 
for the Aspergillus AMPase preparation. The long-term depression produced by 
the guinea-pig homogenate was similar in profile to that produced by the 
AMPase preparation, in that potentials could be restored to control values by 
increasing the stimulation amplitude, also LTP could be elicited using HFS. 
These results reveal the possibility that an endogenous factor present in the brain 
(at least of guinea-pig) may be responsible for long-term depression in the 
hippocampus and opens the question as to the mechanism of such an action.
If p-glucosidase is released by neurones it may act extracellularly 
(postsynaptically) to cleave glucose residues from receptors or change membrane 
properties of neurones, resulting in long-lasting depression of transmission. 
However, the results obtained with conduritol suggest that p-glucosidase activity 
is not involved in the induction of LTD, since the biochemical assay showed that 
p-glucosidase activity was inhibited in the presence of conduritol but slices still 
showed LTD following perfusion. Another factor suggesting that p-glucosidase 
activity is not necessary for the induction of LTD in the hippocampus is that the 
almond form of the enzyme, when perfused over a slice, did not result in LTD. 
However, it may be that an Aspergillus specific form of the enzyme is required to 
produce the effect. If it is not the enzymic properties of the P-glucosidase that 
causes the depression, it may be a consequence of its polypeptide structure acting 
on receptors to activate (or inhibit), yet to be defined, transduction mechanisms. 
It is important to note that the purified protein only had limited homology to the
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p-glucosidase molecule and was not identical to the two Aspergillus forms of the 
enzyme in the database. It is a possibility that the depressant effects described in 
this study are due to a novel protein which possesses a similarity to p-glucosidase 
unconnected to its properties as a mediator of synaptic plasticity.
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CHAPTER 6.
GENERAL DISCUSSION.
The initial intention of this study was to examine the adenosine (PI receptor) and 
ATP (P2 receptor) effects on E-S coupling in the rat hippocampal slice. In fact, 
each section of the study led the work into slightly different avenues.
Purine studies.
The study of adenosine A; and A2 receptor effects on E-S coupling revealed the 
A|\A2 interaction illustrated in Chapter 3. This interaction between adenosine A| 
and A2 receptors could be of biological importance in situations in which the 
levels of endogenous adenosine rise substantially. The levels of adenosine in 
normal brain are in a concentration range of 1 to lOpM (Dunwiddie et a l, 1981; 
Fredholm et a l, 1984; Newman and Mcllwain, 1977). The endogenous 
concentration normally seems able to activate Ai receptors, as antagonists (e.g. 
caffeine, theophylline) have behavioural and electrophysiological effects which 
are normally attributed to inhibition of Aj receptors with no significant 
coiTelation with other actions of these drugs such as phosphodiesterase 
antagonism (Dunwiddie et a l, 1981; Snyder et a l, 1981). In conditions where 
the levels of adenosine in the brain rise, for example in ischaemia, A2A receptors 
may also be activated which would attenuate the inhibitory effects of Ai receptor 
activation on transmitter release and postsynaptic membrane excitability, and 
may reduce the inhibitory and neuroprotective properties of A; receptor 
activation (MacGregor et a l, 1993).
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The examination of the effects of ATP on evoked potentials revealed a LTP 
which became the focus of Chapter 4. As previously mentioned, high frequency 
stimulation of the type that induces LTP preferentially releases ATP. This in 
turn means that a higher proportion of the adenosine in the extracellulai' space 
following high frequency stimulation comes from metabolised ATP. It has been 
shown that adenosine formed from the metabolism of released adenine 
nucleotides preferentially activates excitatory (A2) adenosine receptors in rat 
hippocampal synapses (Cunha et a i, 1996b). A2A receptors have been shown to 
increase presynaptic fluxes (Mogul et al., 1993) and also potentiate postsynaptic 
AMP A responses resulting in NMDA receptor-independent LTP (Kessey and 
Mogul, 1997). Indeed, adenosine A% receptors have been implicated in the 
development of LTP by a number of investigators. The A2A antagonist CP 66713 
has been shown to both inliibit the induction of, and facilitate the reversal of LTP 
(depotentiation) of evoked EPSPs (but not population spikes) in hippocampal 
CAl neurons (Sekino et a l, 1991, Fujii et a l, 1992). Kessy et al (1997) 
provided evidence for the role of adenosine A2B receptors in the induction of 
hippocampal LTP.
This evidence for the involvement of A2 receptors in excitatory transmission 
provided the rationale for the use of the A2A receptor antagonists ZM 241385 and 
CSC in this study. CSC had no effects on the adenosine Ai-receptor-mediated 
inliibition seen during ATP perfusion, but inhibited the following induction of 
LTP, supporting the involvement of A2A receptor activation in LTP. 
Surprisingly, ZM 241385 prevented the inliibition produced during ATP 
perfusion - an effect ascribed to the activation of adenosine Ai receptors by
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adenosine released from the metabolism of ATP, without affecting the 
subsequent LTP, in fact the removal if the inhibitory effect of ATP exposed the 
induction of LTP almost immediately on perfusion of ATP. Why the supposedly 
Al receptor mediated inliibition of responses by ATP should be blocked by an 
A2a receptor antagonist is imclear. Comparison of the binding characteristics of 
ZM 241385 in cortical and striatal membranes indicate a 500-1000 fold 
selectivity for A2A receptors over Ai receptors and no significant activity for 
adenosine A3 receptors (Poucher et al., 1995). The effect caimot be accounted 
for by the use of too high a concentration of ZM 241385 which also blocked Ai 
receptors, since the more selective Ai receptor antagonists reduced the size of the 
LTP. The previous chapter demonstrated an interaction between adenosine A] 
and A2A receptors. An interaction between these receptors in this case seems 
unlikely given the evidence that activation of A%A receptors causes a 
desensitisation-like effect on Ai receptors (Cunlia et a i, 1994a; Dixon ei a l,
1997). An inliibition of Ai effects by antagonism of A2A receptors would involve 
the tonic enliancenient by A2A receptors of Ai receptor inhibitory responses on 
neuronal excitability which would disappear upon A2A receptor blockade, 
directly opposing these studies. An alternative explanation may be that 
adenosine A2A receptors tonically increases the inliibitory drive in the 
hippocampus, which when blocked could raise the threshold for inhibition by A| 
receptor agonists. Activation of A2A receptors have been shown to facilitate the 
release of G ABA from rat synaptosomes (Cunha et a l, 1996c). The xanthine 
A2A receptor antagonist chlorostyryl-caffeine did not produce the same effect on 
ATP induced inliibition of responses as ZM 241385, indicating that the effect is 
probably not attributable to the blockade of A2A receptors. Adenosine A2B
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receptors have been implicated in LTP (Kessy et a l, 1997). Although the 
concentration of ZM 241385 used is selective for A2A receptors, it has been 
shown that ZM 241385 has moderate affinity for human A2B receptors in 
transfected in CHO cells (Ki 50 nM) (Ongini et a l, 1999).
A further mechanism by which ZM 241385 may block the inliibitory effects of 
ATP oil evoked responses is that the structure of the molecule may affect the 
metabolism of ATP to adenosine, for example by blocking ecto-nucleotidases. 
Only a small amount of adenosine need be present for LTP induction to occur, as 
shown by the effects of 2.5 pM ATP. In this scenario, the adenosine released by 
the metabolism of ATP would not be sufficient to cause a significant reduction of 
response size, although subsequent LTP did occur. If ZM 241385 had an 
inliibitory effect on the breakdown of ATP, such that the concentration of 
adenosine produced was of the same order as that produced from 2.5 pM ATP, 
then its effects would be explained. At present, it is only possible to speculate 
that the effect of ZM 241385 is due to a novel action, by which it interferes with 
the processes associated with the PI receptor-mediated depression of evoked 
potentials, but leaves unchanged more proximal steps in A| receptor activation 
needed for the ATP-iiiduced establishment of LTP. The results also highlight the 
importance of taking these effects of ZM 241385 on adenosine Ai receptors into 
consideration when interpreting studies concerned with its A2A antagonism 
effects.
These studies re-affirm the position of purines as modulators of neuronal activity 
in the mammalian brain. Initially, the prospect of purines as messenger
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molecules was greeted with scepticism. Many found it difficult to accept that 
compounds with the ubiquitous distribution and biochemical importance of 
adenosine and ATP could assume the equally fundamental but completely 
unrelated function of neurotransmitters. Indeed, it is possible that these 
compounds originated very early in the earth’s development. It has been shown 
as early as the 1880’s that the purine adenine can be synthesised in a single step 
from ammonia and hydrogen cyanide. As a consequence, it was proposed that 
purines may have been created in the “primordial soup” (warm pools of water, 
methane, carbon dioxide, ammonia and hydrogen) by the action of, for example, 
ultraviolet light, as has been demonstrated in the laboratory. The natural sequel to 
the formation of adenine would be the production of ATP and this provides a 
working hypothesis for the origin and evolution of the components basic to 
human life. In light of this, the argument against ATP and adenosine being 
neurotransmitters due to their ubiquity and biochemical importance can be turned 
on its head. If purine molecules are as old as life itself then it is reasonable to 
argue that during evolution they will become involved in virtually all aspects of 
cellular function. It should come as no sm'prise that they are involved in 
signalling between some of the most evolutionary advanced cell types, namely 
nerve cells.
Future work on the role of purines in neurotransmission, and in particular 
synaptic plasticity, may include the interaction of purines with other modulators 
of neuronal plasticity for example, arachidonic acid, nitric oxide, metabotropic 
glutamate receptors etc. Work could also include the interaction of purine 
molecules with tropic factors responsible for moiphological changes in neuronal
175
G en era l d iscu ssio n
networks leading to long-term changes in plasticity, for example the serine 
protease family (Turgeon and Hoiinenoii, 1997) or a-integrin (Grotewiel et al.,
1998). Another interesting area of investigation would he the identification of 
changes in gene expression such as zif/268, c-fos, or Ca^Vcalmodulin protein 
kinase 11 (CAMKII) following induction of LTP by ATP.
Studies with 5’ adenylic acid.
Previous work with ATP in this lab, together with a desire to determine whether 
the effects of AMPase were due to Pi or P] receptors led into the entirely 
unexpected area of protein purification and the identification of a putatively 
novel modulator of hippocampal plasticity. Other groups have described 
apparent novel or unusual effects of enzyme preparations, which later have been 
found to be attributable to the presence of contaminants arising from the 
commercial extraction of the enzyme. For example, Sugumaran and Bolton 
(1998) have shown that the unusual oxidative conversion of 2,6-dimthoxyallyl 
phenol to its quinone methide, catalysed by commercial preparations of 
mushroom tyrosinase described by Krol and Bolton (1997) was, in fact, due to 
another enzyme - laccase -  a contaminant in the commercial preparation. 
Korecka et al. (1999) proposed that the apparent inhibition of the enzyme inosine 
monophosphate dehydrogenase by mycophenolic acid glucuronide was 
attributable to the presence to trace amounts of contaminant mycophenolic acid. 
No information on the commercial large scale extraction of AMPase from 
Aspergillus species could be obtained from Sigma-Aldrich chemicals, as this was 
deemed classified. Therefore, potential opportunities for contamination in the 
commercial extraction could not be identified. However, the lyophilised powder
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obtained from the company contained approximately 20% protein with the 
balance “primaiily” diatomaceous earth, suggesting that the preparation was not 
entirely pure (a fact illustrated by the SDS-PAGE gel of the crude extract, figure 
5.20). The protein involved in the LTD of potentials seems to originate from the 
Aspergillus species since a perfusion of Aspergillus nidulans homogenate 
resulted in the same effect on slices. The results may also be relevant to 
understanding the serious and often fatal neurological complications such as 
paralysis which accompany invasive cerebral aspergillosis (Pagano et al., 1997; 
Harris, 1997; Guppy et al., 1998). If the activity of the isolated protein can be 
modulated it may provide a basis for the treatment of a disease with a high 
mortality rate (50-100%) and difficult clinical detection. Further work is 
required to establish if there is a connection between the action of the isolated 
protein and the pathogenesis of aspergillosis, this may involve investigating its 
interactions with molecules released during infection e.g. the cytokines.
The study using AMPase extract described in chapter 5 raises the possibility that 
a novel protein has been identified with potent effects on hippocampal plasticity, 
which may provide a useflil pharmacological tool in the continuing investigations 
into the neural basis of memory and learning. It is interesting that a homogenate 
of guinea-pig brain also resulted in a similar profile of depression as the AMPase 
contaminant. If the protein involved in the observed LTD can be released 
physiologically then interfering with its effects could result in an enhancement of 
hippocampal function which could be relevant to drug development. Further 
work is clearly merited on this putatively novel protein, including complete
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structural identification by cloning and sequencing of the gene that codes for its 
expression.
In conclusion, the investigations described above illustrate the ability of
hippocampal CAl neurones to undergo long-lasting plastic changes and, in q
4:
particular, highlights the ability of purinergic compounds to modulate synaptic
transmission. This in turn raises the possibility that drugs which interfere with 
the mechanisms by which purines effect plasticity may be useful as modulators 
of memory and learning. This study also (unexpectedly) raises the possibility
■T
that a new family of proteins, related structurally to glucosidases, has been 
discovered in Aspergillus species (and perhaps also endogenously in guinea-pig 
brain) which may also affect synaptic plasticity. This discovery introduces a new 
member into the field of plasticity modulation, further complicating an already 
complex area, and highlights the intricacies surrounding the mechanisms of 
learning and memory.
Î?-
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